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ABSTRACT 
In vivo Observation of the Release of Norepinephrine and in vivo Optical Studies on the Direct and 
Indirect Paths of the Striatum  
Samuel Clark 
 
This thesis focuses on my work using optical techniques to study different brain regions in vivo. The 
ability to optically study neurons and the circuits they comprise in vivo is an important method to better 
understand their role in the healthy brain and their dysfunction in disease.  
The first part of my thesis focuses on my work using on a collaborative project using a new optical probe 
to study norepinephrine synapses in vivo. In this work we were able to observe the effects of 
amphetamine on norepinephrine release in vivo and observed some evidence of potential silent 
synapses. 
I also describe a new method of cranial window surgery I developed for optical imaging. This technique 
called PHASOR, is faster, and has a higher success rate, than traditional surgical methods. The 
improvements demonstrated in this new surgical technique may enable more widespread use of optical 
imaging methods.  
In the second part of my thesis, I used optical techniques to study the dorsal striatum in vivo in awake 
behaving mice. The direct and indirect paths of the dorsal striatum play an important role in motor 
behavior and motor learning. Dysfunction in these paths has been implicated in motor diseases as well as 
in mood disorders. In this thesis, I provide a review of the anatomy and physiology of the neurons that 
comprise the dorsal striatum, and the circuits that they form. The next chapters describe my work using 
optical techniques to record from these neurons in vivo.  
In my first set of experiments, I recorded from the direct and indirect paths during a behavioral task of 
anxiety and observed differential firing depending on the anxiety state of the mouse.  
Finally, in a preliminary set of experiments, I record from the direct and indirect paths during tasks of 
motor learning. I found that both paths show changes in firing during motor learning and that these 
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PART 1: IN VIVO STUDY OF NOREPHINEPHRINE__________________________________________ 
CHAPTER 1: GENERAL INTRODUCTION TO NOREPINEPHRINE AND FFNS  
OVERVIEW 
In this chapter I provide a brief review of the role of norepinephrine (NE) in the CNS and its dysfunction in 
disease. I also introduce a new optical method to enable direct observation of release in vivo. The 
following chapters describe the collaborative studies I and other members of the Sulzer, Sames, and 
Kandel labs performed on this system. These studies provide the first optical observation of release in 
vivo and the first optical observation of the effects of amphetamine in vivo.  
 
THE ROLE OF NOREPINEPHRINE 
NE plays important roles in both the central nervous system (CNS) and peripheral nervous system (PNS). 
It is synthesized from dopamine (DA) by DA beta hydroxylase (DBH). In the cortex and hippocampus, NE 
modulates cognitive functions including working memory, attention, decision making, and sensory 
processing (Mehta et al. 2001, Clayton et al. 2004, Sara 2009). The major CNS population of neurons 
that release NE reside in the locus coeruleus (LC) in the brain stem and project to both cortical and 
subcortical areas, and can release DA as well as NE (Berridge and Waterhouse 2003, Kempadoo et al. 
2016). 
NE signals through three major G-protein coupled receptors, known as alpha 1, alpha 2, and beta 
receptors. Alpha 1 receptors are located post synaptically and increase calcium influx through Gq 
signaling, while alpha 2 receptors are chiefly located presynaptically and function as auto receptors to 
reduce NE release (Nguyen et al. 2017). The neurons of the LC exhibit tonic firing that modulate arousal 
levels and wakefulness. In response to salient stimuli, the LC neurons display phasic bursting (Berridge 
and Devilbiss 2011). NE released through phasic bursting plays an important role in attention through 
actions in the prefrontal cortex (PFC). Rodent studies of lesions of the NE projections to the PFC have 
shown deficits in cognitive processing. In primates, reduced NE release by application of an alpha 2 
agonist impairs attention and working memory (Ramos and Arnsten 2007). 
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Both DA and NE play important roles in modulating attention through activity at the PFC (Campo et al. 
2011). NE and the NE transporter (NET) work to modulate DA signaling and attention. Interestingly, DA 
binds to the NET transporter with a higher affinity than to the DA transporter DAT. In the PFC, there are 
very low levels of DAT and high levels of NET that modulate extracellular DA levels (Moron et al. 2002). 
In addition, the enzyme catechol-o-methyltransferase (COMT) breaks down DA in the PFC (Scheggia et 
al. 2017). Thus, DA signaling is regulated by both COMT mediated breakdown as well as by NET 
mediated reuptake.  
NOREPINEPHRINE DYSFUNCTION IN DISEASE  
NE dysfunction plays an important role in the cognitive deficits of several disorders. Parkinson’s disease 
is characterized by the loss of DA neurons in the substantia nigra pars compacta (SNc), resulting in the 
loss of the nigrostriatal DA path. This results in changes in output of the medium spiny neurons of the 
dorsal striatum and severe motor deficits (Hoehn and Yahr 1967, Dickson et al. 2009). However, 
Parkinson’s disease also results in severe cognitive deficits such as impairment in attention, working 
memory, and cognitive flexibility (Halliday et al. 2008, Leverenz et al. 2009). These cognitive symptoms 
can precede the motor symptoms by many years (Keri 2010). In addition to the loss of dopaminergic 
neurons, there is also substantial loss of the NE neurons of the LC (Sulzer and Surmeier 2013). It is 
thought that the loss of the NE neurons projecting to the frontal cortex plays a significant role in the 
cognitive symptoms of Parkinson’s disease (Vazey and Aston-Jones, 2012).  
Individuals with genetic DBH deficiency from birth possess normal NE receptors, but lack the ability to 
synthesize NE. This results in problems with the autonomic nervous system and symptoms such as 
hypotension and dizziness. Interestingly, cognitive tests in DBH deficient individuals have not found any 
cognitive deficit. This suggests that if NE is absent from birth, other neurotransmitter systems are able to 
completely compensate in cognitive processing (Jepma et al. 2011). 
 Attention deficit hyperactivity disorder (ADHD) is the most common childhood mental disorder affecting, 
5% of children in the US (Danielson et al. 2017). One of the most commonly prescribed first line 
treatments is amphetamine (AMPH) (administered as Dexedrine or Adderall), a stimulant with both 
therapeutic effect and a high potential for abuse and addiction. While amphetamine’s potential for abuse 
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is dependent on its action on the dopaminergic synapses of the striatum, it also exerts potent actions at 
noradrenergic synapses of the cortex.  
NOREPINEPHRINE AND AMPHETAMINE 
It has been hypothesized that AMPH’s ability to increase cortical levels of NE and, indirectly cortical DA, 
is due to actions at the NE transporter (NET), and that this may underlie much of its therapeutic effect for 
ADHD (Berridge and Devilbiss 2011, Campo et al. 2011) in a manner independent from its effects on 
striatal DA levels.  
The mechanism by which AMPH increases DA levels has been extensively studied. The major 
mechanism by which AMPH raises DA levels is by redistributing vesicular DA to the cytosol, followed by 
reverse transport of cytosolic DA through DAT, and to more controversially, by causing vesicular fusion, 
as well as blocking reuptake through DAT and NET (Sulzer 2011). Despite its widespread therapeutic 
use, the mechanism by which AMPH raises cortical levels of NE is controversial. This controversy led a 
recent review (Berridge and Devilbiss 2011) to conclude that at clinically relevant concentrations, AMPH 
only increases NE levels by reuptake blockade, and that only very high concentrations can AMPH cause 
NE release. In contrast, other studies show that AMPH responses in vivo are consistent with driving NE 
release. The effects of AMPH occur quickly and increase NE levels far beyond traditional NE uptake 
blockers (up to 450%) followed by a rapid decrease (Heal et al. 2013).  
This controversy spans several decades. In one of the first studies of the mechanism of AMPH on NE, 
Raiteri (1975) used radiotracers to show that AMPH had little effect on NE release compared to DA. They 
concluded that reuptake block was amphetamines primary mechanism by which it increases NE, while 
AMPH acts on DA terminals to both inhibit reuptake as well as to stimulate release.  
Kuczenski and Segal (1992), used in vivo microdialysis to show that AMPH causes an increase in NE at 
dosages of 2.5mg/kg. They conclude that this may be mostly due to reuptake block and possibly release, 
but only at very high dosages. Florin (1994) used microdialysis in rats to measure NE levels. They 
administered clonidine, an alpha2 receptor agonist, and AMPH to examine AMPH induced increases in 
NE. They concluded that at 0.5mg/kg, clonidine reduced NE neuronal firing, and that AMPH-induced 
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increase in NE levels was dependent on AMPH blockade of reuptake. In contrast, higher dosages of 5.0 
mg/kg were not sensitive to clonidine, and they concluded that AMPH caused NE release from vesicular 
storage sites at these concentrations.  In contrast, Rothman (2001) used in vitro measurement of 
radiolabeled NE in synaptosomes prepared from rat caudate tissue. By administering AMPH in the 
presence and absence of reserpine, they found that AMPH caused NE release. However, these in vitro 
results were not verified in vivo.  
FLUORESCENT FALSE NEUROTRANSMITTERS 
Many of the mechanisms governing NE release and the action of AMPH have not been addressed in vivo 
due to previous limitations of in vivo tools for imaging neurotransmission (NT) (Figure 1). FFNs are 
fluorescent substrates for the catecholamine/serotonin vesicular transporters (VMATs), and for some 
FFNs including FFN270, for DAT and NET. FFNs including 270 are thus accumulated into the presynaptic 
synapse and loaded into synaptic vesicles. When concentrated in the vesicle, they fluoresce brightly, 
providing a means for visualization of their accumulation into the presynaptic bouton. When vesicle fusion 
occurs, the FFNs are released into the synaptic cleft and diffuse from the synapse, causing destaining of 
the bouton. This allows imaging of NT from dopaminergic and noradrenergic synapses in real time 
(Gubernator et al. 2009). The use of FFNs overcomes several limitations common to other in vivo 
techniques. For instance, in vivo microdialysis provides a bulk measurement of the overall sum of 
synaptic release and reuptake in an area over a slow time frame (typically > 20 min per sample). While 
cell-based neurotransmitter fluorescent engineered reporters (CNiFERs) have rapid response times, they 
provide a summed measurement of DA or NE in the area of the implanted reporter cell (Muller et al., 
2014). Cyclic voltammetry in vivo may measure release of hundreds of synapses and therefore does not 
allow for single synapse resolution, nor can it distinguish between DA and NE, both of which are present 
in the mPFC. Finally, calcium indicators (GCaMPs and GECIs) provide a measure of cell firing rate, and 
an indirect measure of calcium transients in axon terminals, but do not show the kinetics of synaptic 
vesicle fusion and neurotransmitter release (Chen et al. 2013).  
While FFNs have been used in acute brain slice preparations (Rodriguez et al. 2013, Pereira et al. 2016), 
their use in vivo is a novel application. In this research project, I optimized the use of fluorescent false 
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neurotransmitters (FFNs) in vivo and have characterized AMPH-induced release of DA and NE in wild 
type (WT) mouse cortex. Here we report the first in vivo optical observation of synaptic vesicle exocytosis 
in the mammalian brain, as well as a means to determine AMPH’s action at noradrenergic synapses with 

















Figure 1. Limitations of different in vivo imaging techniques. In vivo microdialysis measures a signal 
from numerous synaptic sites and at best has a temporal resolution of minutes. Multiphoton calcium 
imaging has single synapse resolution but measures calcium as a proxy for neuronal activity. Similarly, 
voltage indicators do not measure actual synaptic vesicle fusion. In vivo cyclic voltammetry does not have 
single synapse resolution. Cnifers signal from multiple synapses and lack real time kinetics. Other 
imaging methodologies such as MRI, SPECT, and PET measure activity over large brain regions. Only 
FFNs can resolve single synapses with real time kinetics. Because they are released when vesicles fuse, 
they have the potential to measure vesicle fusion. 
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CHAPTER 2: PRELIMINARY AND CONTROL STUDIES WITH FFNS 
OVERVIEW 
In this chapter, I describe several preliminary experiments that I performed to optimize the technique of 
using FFNs in vivo. Because FFNs had not previously been used in vivo, there were a number of 
preparations that were necessary to optimize this novel system.  
FFN LOADING 
FFN270 can be loaded into the brain through a chronic implanted optical glass window. For this set of 
experiments, I used the novel FFN, FFN270. This new FFN was designed to have a high specificity as a 
substrate for the NE transporter (NET). The first step to optimize FFN270 for use in vivo was to develop 
an optimal method by which they could be introduced into the brain tissue prior to imaging. Multiphoton 
Figure 2. Diagramed image of an implanted cranial window with a chronic glass port for 
nanoinjecting FFN. The FFN injection needle is lowed through the open port in the optical glass 
window allowing loading of the FFN. The window is affixed to the skull with dental acrylic.  
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imaging through a cranial window often uses a surgically implanted glass coverslip. However, this 
coverslip would impair the loading of the FFN via nanoinjection into the tissue. This problem was solved 
by using a diamond tipped drill bit to bore a hole into the cranial window glass coverslip. This allowed the 
FFN to be loaded through the microwindow into the brain tissue (Figure 2). The hole in the cranial 
window was then plugged with silicone glue that could be removed allowing reloading of the FFN at 
different time points and chronic imaging experiments.  
Novel fluorescent cocaine analogue ECN127 pretreatment blocks loading of FFN270  
The next in vivo experiment was conducted in collaboration with members of the Sames lab. We 
performed a control experiment to verify that loading of the FFN could be blocked by pretreatment with a 
NET inhibitor. We nanoinjected FFN270 twenty minutes after we first pre-injected a fluorescent NET 
antagonist ECN127 (Figure 3). This control allowed realtime visualization of the specificity of FFN270 for 
NET, allowing us to visualize if FFN270 would load into the puncta through other mechanisms that were 
not mediated by NET. ECN127 is a rhodamine fluorophore linked to a tropane analog of cocaine. The 
resulting compound is a fluorescent DAT/NET inhibitor. We found that pretreatment with ECN127 blocked 
FFN270 loading (Figure 4). This confirmed specificity of FFN270 loading to NET.  
Targeting the LC with a viral vector 
Finally, we performed an experiment to verify that we could target the LC with a viral vector. In a later 
experiment channelrhodopsin was injected into the LC and we released FFN270 from the cortex with 
optical stimulation. The details of the channelrhodopsin experiment are described in chapter 3. In this 
preliminary experiment we injected AAV virus expressing a hemagglutinin (HA) tag. We then performed 
immunostaining against tyrosine hydroxylase (TH) and hemagglutinin to double label the brain sections 
and verify expression of the virus in the LC. We found that we were able to successfully target the LC and 







Figure 3. Diagram of ECN127 experiment. The NE projections to the cortex from the LC are shown 
in green. A cranial window was performed an ECN127 was injected into the cortex prior to FFN270. 










Figure 4. Pretreatment with NET inhibitor ECN127 blocks FFN270 loading. Pretreatment with 
ECN127 results in fewer visualized FFN270 puncta than a control animal injected with only FFN270 (top 
left). Brain tissue injected with ECN127 (blue 3D projection) shows very few puncta. In contrast, brain 
tissue injected with only FFN270 shows significant amounts of puncta (green 3D projection). ECN127 is 








Figure 5. Immunostaining of viral injection into the LC. A viral vector expressing the epitope HA 
was injected into the LC. Six weeks post injection, the mice were perfused and the brain was sectioned. 
Sections were immunostained for HA (left) and TH (middle). The right panels show the overlap between 





Adult 8 week old male wild type C57BL/6J mice were used for the imaging experiments here. . All 
procedures were conducted in accordance with Institutional Animal Care and Use Committee (IACUC) of 
the New York State Psychiatric Institute.  
Cranial window surgery 
Mice were anesthetized with isoflurane (1-4%). The depth of anesthesia was monitored by both the 
animal’s response to toe-pinch every 5 min and observation of respiratory rate.  Once the proper depth of 
anesthesia was reached, the animal was placed in a small animal stereotactic apparatus on top of a 
heating pad and Puralube vet ointment was applied to the eyes to prevent vision loss. All surgical 
procedures were performed in a sterile manner. Marcaine (0.5%) with saline 1:2 (0.25%) (2 mg/kg), was 
injected subcutaneously along the midline of the scalp as a local anesthetic. Before the incision, the hair 
over the scalp area was removed with NAIR and sterilized with a gentle scrub with Betadine on a sterile 
cotton swab, followed by 70% ethanol, repeated 3 times. The scalp was then removed with surgical 
scissors, membranes over the skull were removed by scraping, and the exposed bone was dried with 
compressed air. A 3 mm cranial imaging window was then made over the barrel cortex with a high speed 
dental drill (Midwest Stylus 360). The meninges were inspected to make sure there was no damage. Any 
bleeding from the bone was stopped with an application of collagen foam (Avitene Ultrafoam, Bard 
Davol). A cranial window with a microinjection port was then affixed over the window with dental acrylic. A 
glass pipette attached to a Nanoject II (Drummond Scientific) was filled with a 1 500nnM solution of 
ENC127 and was then injected through the microinjection port in the cranial window into the brain at 
coordinates AP: -0.9 mm to -1.0 mm and ML: 3.0 mm, over several depths (DV: 100 µm, 50µm, and 20 
µm) with 3 minutes of delay per depth. After 30 minutes, 100 nl of 1mM solution of FFN270 diluted in 
ACSF was then injected into the same coordinates. The glass pipette was then withdrawn from the brain 
and the mouse was then injected with ketamine (100 mg/kg) and xylazine (10 mg/kg) i.p. and then 
weaned off of isoflurane while making sure to maintain depth of anesthesia. The mouse was then 
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headfixed under the multiphoton microscope for imaging. The body temperature of the mouse was 
maintained for the duration of imaging with a heating pad. 
Viral injection surgery 
Mice were injected with buprenorphine (0.05- 0.1 mg/kg) prior to anesthesia and anesthetized with 
isoflurane (1-4%). Marcaine diluted 50% in saline was injected under the scalp to provide local anesthetic. 
The body temperature of the mouse was maintained for the duration of imaging with a heating pad. The 
depth of anesthesia was monitored by both the animal’s response to toe-pinch every 5 min and 
observation of respiratory rate.  Once the proper depth of anesthesia was reached, the animal was placed 
in a small animal stereotactic apparatus on top of a heating pad and Puralube vet ointment was applied to 
the eyes to prevent vision loss. All surgical procedures were performed in a sterile manner. Marcaine 
(0.5%) with saline 1:2 (0.25%) (2 mg/kg), was injected subcutaneously along the midline of the scalp as a 
local anesthetic. Before the incision, the hair over the scalp area was removed with NAIR and sterilized 
with a gentle scrub with Betadine on a sterile cotton swab, followed by 70% ethanol, repeated 3 times. 
The scalp was then removed with surgical scissors, membranes over the skull were removed by scraping, 
and the exposed bone was dried with compressed air. A 1 mm hole was then made over the dorsal 
striatum with a high speed dental drill (Midwest Stylus 360). Any bleeding from the bone or dura was 
stopped with an application of collagen foam (Avitene Ultrafoam, Bard Davol). A glass pipette attached to 
a Nanoject II (Drummond Scientific) was filled with AAV virus expressing hemagglutinin (300 nl of 1013 
viral units/ml), and attached to the stereotax. A volume of 300ul of virus was injected into the LC with 3 
minutes of delay per depth. The glass pipette was then withdrawn from the brain and the scalp was 
sutured closed. The mouse was then transferred to a heated cage to recover.  
Immunohistochemistry  
Brain tissue preserved with paraformaldehyde was cut into 100um sections on a vibratome. 
Immunohistochemistry was performed as described in Clark et al. 2017.   
Discussion  
We found that FFN270 could successfully be utilized to study NE terminals in the mouse barrel cortex in 
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vivo through a cranial window. We also found that FFN270 labeling of puncta could be blocked by 
pretreatment with a novel fluorescent DAT/NET antagonist. Finally, we were able to successfully transfect 
the LC with an AAV viral vector, which is the first step before attempting viral transfection with 
channelrhodopsin expressing viruses. The experiments described here formed the basis for the more 
advanced studies described in the following chapter. Through this preliminary work, we were able to 

















Chapter 3: Design of a Norepinephrine Optical Tracer for Imaging Individual 
Noradrenergic Synapses and Their Activity in vivo 
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NE is a monoamine neurotransmitter with a wide repertoire of physiological roles in the peripheral and 
central nervous systems. Despite major strides in understanding the noradrenergic system, there are no 
experimental means to study functional properties of individual noradrenergic synapses in the brain. As 
learning and behavior adaptation depend on the ability of specific synapses to undergo changes in 
transmission efficiency, development of new approaches for imaging synaptic neurotransmission is of 
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fundamental importance. Here we introduce fluorescent false neurotransmitter 270 (FFN270), an organic 
dye-based tracer of NE that integrates key structural features of NE with the coumarin fluorophore. 
FFN270 is a fluorescent substrate of the NE transporter and vesicular monoamine transporter, and thus 
labels noradrenergic neurons and their synaptic vesicles. FFN270 enables imaging of synaptic vesicle 
content release from single release sites in living rodents. Combining FFN270 imaging and optogenetic 
stimulation, we found heterogeneous release properties of noradrenergic synapses in the somatosensory 
cortex, identifying populations of low and high releasing synapses. We also observed rapid release of 
synaptic vesicle content induced by systemic AMPH administration, yielding insight into the drug’s effect 
on cortical noradrenergic synapses. 
 
INTRODUCTION 
NE is the major neurotransmitter of the sympathetic peripheral nervous system and regulates 
most visceral organs and glands, thermoregulation, and the immune system NE is also a key 
neurotransmitter in the central nervous system (CNS) (Wassall 2009). Brain NE neurons primarily 
originate in the locus coeruleus (LC) and project axons throughout the CNS, including to the cortex, 
hippocampus, hypothalamus, amygdala, cerebellum, and spinal cord (Fig. 1C) (Foote et al 1983, 
Schroeter et al. 2000, Berridge and Waterhouse 2003  Accordingly, the NE system plays numerous 
physiological roles, such as brain-wide regulation of neurovascular coupling and cerebrospinal fluid flux 
(Bekar 2012), and local effects such as modulation of cortical neuronal circuitry (Sara 2012).  
While it is well established that the LC-NE system regulates stress responses, arousal, and 
sleep-wake cycles, more recent reports also suggest specific functions in cognition (Sara 2007, Sara and 
Bouret 2012). Shifts in LC neuronal firing between tonic and phasic activity control decision-making 
processes and facilitate optimization of behavior in a changing environment. In the “adaptive gain and 
behavior optimization hypothesis,” LC neuronal firing controls the balance between exploitation of the 
ongoing task versus exploration of new ones (Aston-Jones and Cohen 2005) NE synaptic inputs reset the 
activity states and firing patterns of ensembles of cortical neurons, presumably by modulating the 
responsiveness of these cells via activation of adrenergic receptors (Sara and Bouret 2012).  
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The NE system has also been implicated in numerous neurodegenerative and psychiatric 
disorders. For example, in Parkinson’s disease, degeneration of LC-NE neurons often precedes loss of 
DA neurons in the substantia nigra; (Vazey and Aston-Jones 2012) in Alzheimer’s disease, the most 
extensive loss of sub-cortical neurons occurs in the LC (Zarow et al. 2003, Braak and Del Tredici 2011, 
Iba et al. 2015). Modulators of NE neurotransmission represent an important class of widely used 
therapeutics, including adrenergic receptor agonists/antagonists, and modulators of NE storage, release, 
and reuptake. For example, the antidepressant mirtazapine is an α2 receptor blocker, and the 
antidepressant reboxetine is an inhibitor of the plasma membrane NE transporter, NET (Moret and Briley 
2011, Zhou 2004). AMPH, presently administered under the tradename Adderall, is used for treating 
attention deficit hyperactivity disorder (ADHD) (Zhour 2004), and is prescribed to hundreds of thousands 
of children in the US, and self-administered by millions worldwide (Degenhardt and Hall 2012). AMPH 
enhances NE (and DA) transmission (Amara 1998, Rothman and Baumann 2003, Ventura et al. 2003), 
although, whether the effects are due to NET inhibition or the redistribution of stored NE content (e.g. via 
reverse transport) at physiological concentrations has long been debated (Rothman et al. 2001, Spencer 
2015). However, despite the growing importance of the LC-NE system, there previously have been no 
experimental tools to study NE release at the level of discrete synapses, and thus the release properties 
of sparse cortical NE axons and synapses in vivo remained unknown.  
The synaptic hypothesis of learning – which posits that ongoing alteration of synaptic 
transmission underlies an organism’s ability to learn and change behaviors – is gathering experimental 
support (Nabavi 2014). Further, even individual synapses formed by the same axon (Bamford et al. 
2004), are presumably regulated by ongoing expectation and experience to be more or less likely to 
participate in subsequent neurotransmission. To determine how behavior and sensory input alter specific 
synapses, novel tools to measure neurotransmission at individual synapses in vivo must be developed 
and implemented.  
The current approaches for measuring NE lack the spatial and temporal resolution to discern 
individual synapses in the living brain.  While electrochemical detection can distinguish DA from NE in 
some contexts (Park et al. 2011, Bian et al. 2010, Lu et al. 2004), these approaches have insufficient 
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spatial resolution to detect NE release from individual synapses (Sames et al. 2013), and are not useful in 
sparsely innervated regions of the CNS like the neocortex (Herr et al. 2012). New fluorogenic cell-based 
sensors can detect changes in the cortical NE in vivo with high sensitivity; however, these approaches 
also lack the spatial resolution to distinguish individual synapses (Nguyen et al. 2010, Muller et al. 2014). 
Fluorogenic receptor-based sensors have been developed to selectively detect glutamate concentration 
changes in the brain with single synapse resolution (Marvin et al. 2013, Namiki et al. 2007, Okubo et al. 
2010, Hires et al. 2008), but similar sensors for monoamine neurotransmitters have not yet been 
developed. Chemical labels can be used for detection of NE with adequate spatial resolution, such as 
glyoxalic-acid-induced fluorescence histochemistry in fixed tissues (Carelsson et al. 1962, Lindvall and 
Bjorklund 1974) and more recently, fluorogenic chemosensors that react with NE in large dense core 
vesicles of cultured cells( Secor and Glass 2004, Hettie et al. 2013), but these techniques have not been 
adapted to living tissue. 
Here we introduce the use of the fluorescent false neurotransmitter (FFN) concept to provide an 
optical tracer of NE neurotransmission (Gubernator et al. 2009). Several generations of fluorescent DA 
mimetics have been developed in our laboratories, which revealed the heterogeneous nature of 
dopaminergic presynaptic activity in mouse brain tissue (Rodriguez et al. 2013, Pereira et al. 2016). 
FFN102 is an exemplar dopaminergic FFN (Fig. 6), deriving its labeling selectivity for dopaminergic 
neurons as a substrate of the plasma membrane DA transporter (DAT) (Rodriguez et al. 2013, Lee et al. 
2010). As shown below, however, FFN102 is not a substrate for the NET, and thus a poor optical tracer 
for NE.  
We now expand the scope of the FFN concept by introducing the first NE-FFN, probe FFN270 
(Fig. 6). This compound is designed as a fluorescent NET substrate and also a substrate of the neuronal 
vesicular monoamine transporter (VMAT2), the transporter responsible for packaging neurotransmitter in 
monoaminergic synaptic vesicles. The probe is taken up along with NE into synaptic vesicles within NE 
axonal varicosities and enables measurement of synaptic vesicle content release by destaining during 
exocytosis. FFN270 enables both an examination of noradrenergic microanatomy and an observation of 
synaptic activity in the cortex of intact neuronal circuits in vivo. The use of FFN270 also demonstrated 
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that exposure to pharmacologically relevant concentrations of AMPH has a dramatic effect on cortical NE 
axons, providing new insights to the drug’s mechanism of action.  
METHODS 
Synthesis and Preparation of NE-FFN Leads 
Detailed synthetic routes and confirmation of compound identities is included in Supplementary 
Information. 
Photophysical Characterization and Measurement of log D values 
General – Photon absorption and emission spectra were measured using a BioTek H1MF plate reader on 
bottom read mode. 
Absorption - UV absorption spectra were taken by adding probe (4 μL of 10 mM stock solution in DMSO) 
to 996 μL of PBS buffer at different pH values (final probe conc. = 40 μM) in a clear-bottom white 96-well 
plate. 
Emission/Excitation - Excitation/emission spectra were taken by adding probe (5 μL of 40 μM solution in 
PBS) to 995 μL of PBS buffer of different pH values (final probe conc. = 0.2 μM) in a clear-bottom white 
96-well plate. 
pKa - The pKa values of probes were determined from the absorption spectra. The absorbance λabs, max of 
the red-shifted peak was plotted versus pH of the PBS solution; the data were fit to a sigmoid curve using 
GraphPad Prism 5 software to determine the pKa value. 
log D - The log D values were determined by a traditional shake flask method. Each measurement was 
performed in duplicate as follows. First, 20 μM probe solution in 1 mL PBS (pH 7.4) was prepared to 
which 1 mL of n-octanol was added and mixed thoroughly. The mixture was kept in dark for 3 days for 
complete equilibrium, and the concentrations of probe in each layer were determined based on the UV 
absorbance. Log D values were determined based on the following equation; log D = log[probe]oct – 





Characterization and Measurement of probe uptake in transfected cell culture  
Fluorometric assay for evaluation of hNET substrate activity 
Stably hNET-transfected HEK cells were seeded at a density of 0.08-0.09 x 106 cells/well in white solid-
bottom 96-well plates and allowed to proliferate in growth medium for ~2 days at 37 ºC to reach 
confluence. On the day of the experiment, the complete growth medium was aspirated, wells were 
washed with 200 μL PBS, and treated with 100 μL experimental medium with DMSO (vehicle, 0.02% v/v) 
or nomifensine (2μM). The cells were incubated for 60 min at 37 °C, and experimental compounds (100 
μL /well of 10 μM solution in experimental medium with DMSO (vehicle) or nomifensine 2μM) was added 
for a final concentration of 5μM compound in wells. Cells were then incubated for 30 min at 37 ºC. The 
experiment was terminated by two rapid PBS washes (200 μL/well) followed by addition of fresh PBS 
buffer (120 μL/well). The fluorescence uptake in cells was immediately recorded using a BioTek H1MF 
plate reader (3x3 area scan, bottom read mode) with excitation and emission wavelengths set at 370 nm 
and 460 nm respectively. 
Quantification of hNET substrate activity 
Substrate activity was determined using signal to basal ratio (S/B): mean fluorescence uptake (with 
DMSO vehicle) divided by that in the presence of nomifensine. Data presented as normalized uptake ± 
SEM from three independent experiments (eight separate measurements per condition per experiment). 
Fluorescence microscopy imaging of probes in hNET-HEK cells 
hNET-HEK cells or their respective controls, HEK293, were plated onto poly-D-lysine (Sigma Aldrich, 
conc. = 0.1 mg/mL) coated clear bottom six-well plates at a density of 0.15-0.20 x 106 cells per well and 
grown at 37° C in 5% CO2. Following ~4 days of growth, the cells had reached 80-90% confluence. The 
culture medium was removed by aspiration, and the cells were washed with PBS (Invitrogen, 1.0 
mL/well). To investigate the inhibitory effects of nomifensine maleate salt (Sigma-Aldrich) and cocaine 
hydrochloride salt (Sigma-Aldrich) on probe uptake, cells were incubated in 0.9 mL of experimental media 
containing the inhibitor (2 μM prepared from 10 mM stock solution in DMSO) or DMSO vehicle as a 
control at 37° C in 5% CO2 for 1 h. The compound uptake was initiated by adding 0.1 mL of experimental 
media containing probe (200 μM, prepared from a 10 mM stock solution in DMSO, with a final probe 
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concentration of 20 μM in the uptake assay) with and without nomifensine (2 μM) or cocaine (1 μM). 
Following incubation at 37° C in 5% CO2 for 30 min, the media was removed by aspiration and the cells 
were washed with PBS (1 mL/well) and maintained in fresh experimental media (1 mL/well). Fluorescence 
images (at least 3 images/well in duplicate wells) were acquired with a Leica FW 4000 imaging system 
(Leica Microsystems) equipped with a Chroma custom filter cube (ex = 350 ± 25 nm, em = 460 ± 25 nm; 
Chroma Technology Corporation) and a Leica DFC-360FX camera. Fluorescence and bright field images 
were acquired with exposure time set at 600 ms and 37 ms respectively. All images were adjusted using 
the same contrast and brightness level using ImageJ software (National Institutes of Health). 
Fluorescence microscopy imaging of probes in VMAT-HEK cells 
Epifluorescence microscopy of the small library of experimental coumarins reported here was conducted 
as previously reported using VMAT-HEK and control tetR-HEK cells.  Briefly, VMAT-HEK and TetR-HEK 
cells were plated at a density of 0.15-0.20 x 106 cells per well on poly-D-lysine coated 6-well optical plates 
(Falcon) and grown at 37° C in 5% CO2. Following ~4 days of growth, the cells had reached 80-90% 
confluence. The culture medium was removed by aspiration, the cells were washed with PBS (Invitrogen, 
1.0 mL/well), and the wells were pretreated with experimental medium with or without the VMAT2 
inhibitors reserpine (1 µM, Sigma-Aldrich) or dihydrotetrabenazine (DTBZ, 2 µM; Sigma-Aldrich) for 
approximately 60 minutes.  To initiate uptake, solutions of experimental probe with or without inhibitor 
were added to the appropriate wells for a final concentration of 20µM probe with or without reserpine (1 
µM) or DTBZ (2 µM). Cells were incubated at 37˚C for 2 h, at which point the probe solutions were 
removed by aspiration and wells were gently washed with PBS (2 mL). Wells were maintained in fresh 
experimental medium and were imaged as described above. 
Quantification of VMAT2 substrate activity 
The Multiple Thresholds ImageJ plug-in (created by Damon Poburko, Simon Fraser University, Burnaby, 
BC, Canada) was used for quantification of fluorescent puncta in images of VMAT2-HEK cells obtained 
from fluorescence microscopy. Puncta were identified as objects conforming to defined parameters: 
brightness (> 0.6 SDs above background), appropriate size (0.5 – 4 µm2), rounded shape (min circularity: 
0.6), and well delimited boundaries. Data presented as mean intensity of these puncta structures per 
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image, normalized to uptake by tetR-HEK cells as background ± SEM from four independent experiments 
(six images per condition per experiment). 
 
Determination of FFN Loading and Release in Acute Murine Brain Slices 
Preparation of acute murine brain slices 
All animals used for slice preparation were C57BL/6 mice obtained from the Jackson Laboratory (Bar 
Harbor, ME). For slices containing the locus coeruleus, animals were sacrificed at 20 days due to peak 
NET expression at an early age (Sanders et al. 2005). For all other experiments mice were used at 7-9 
weeks. All animal protocols were approved by the IACUC of Columbia University. Mice were decapitated 
and acute 300 µm thick coronal slices were cut on a Leica VT1200 vibratome (Leica Microsystems) at 
4oC and allowed to recover for 1 h in oxygenated (95% O2, 5% CO2) artificial cerebrospinal fluid (ACSF) 
containing (in mM): 125 NaCl, 2.5 KCl, 26 NaHCO3, 0.3 KH2PO4, 2.4 CaCl2, 1.3 MgSO4, 0.8 NaH2PO4, 10 
Glucose (pH 7.2-7.4, 292-296 mOsm/l). Slices were then used at room temperature for all imaging 
experiments. 
Application and 2-photon imaging of FFNs 
Slices were incubated with the FFN (10 µM) for a 30 min bath incubation and then transferred to an 
imaging chamber (QE-1, Warner Instruments, Hamden, CT) and held in place by platinum wire and nylon 
string custom made holder and superfused  (1 ml/min) with oxygenated ACSF (Wong et al. 2011). Slices 
were allowed to wash in the perfusion chamber for at least 10 min before imaging. For any inhibition 
experiments, slices were first pre-incubated with the inhibitor (1 µM nomifensine or 500 nM reboxetine) for 
15 min, and then co-incubated with the FFN for the 30 min loading period. Inhibitor was also added to the 
perfusing ACSF solution. Fluorescent structures were visualized at depths of at least 25 µm from the slice 
surface using a Prairie Ultima Multiphoton Microscopy System (Prairie Technologies, Middleton, WI) with 
a titanium-sapphire Chameleon Ultra II laser (Coherent) equipped with a 60 X 0.9 NA water immersion 
objective. FFN270 was excited at 760 nm and 440-500 nm light was collected. Images were captured in 
16-bit 112 x 112 µm2 field of view at 512 x 512 pixel2 resolution and a dwell time of 10 µs/pixel using 
Prairie View software. For imaging the sparse noradrenergic cortical projections 20 µm thick z-stacks (1 
µm/image) were collected and then compressed using a maximum z-projection. 
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Colocalization of FFN270 and TH-GFP 
Colocalization of FFN270 and noradrenergic structures was performed in animals that express GFP 
under the tyrosine hydroxylase promoter (TH-GFP) (Sawamoto et al. 2001). Acute slices from the LC or 
barrel cortex were incubated with FFN270 as described above and imaged using interlaced scanning with 
two separate lasers. FFN was imaged using 740 nm excitation and an emission range of 435-485 nm, 
and GFP was imaged using 920 nm excitation and an emission range of 500-550 nm. To quantify the 
number of GFP-positive cells in the LC that colocalize with FFN, cells were manually selected if they 
contained fluorescence in either channel that was greater than 2 standard deviations above background, 
and reported as the percentage of GFP-positive cells that also contain FFN270 signal.  Quantification of 
the colocalization of noradrenergic projections in the barrel cortex was determined by identifying FFN270 
puncta using the Multiple Thresholds plug-in for the ImageJ software. Any ROIs that corresponded to 
fluorescence in blood vessels were manually discarded. The identified ROIs were then considered to 
positively colocalize if greater than 50% of the pixels overlapped with GFP signal that was greater than 2 
standard deviations above background, and reported as the number of visibly discernable GFP axons 
with FFN270-postive puncta. 
Electrical stimulation of FFN270 loaded cortical projections 
For better temporal resolution (15 s/frame), imaging during electrical stimulation experiments used a 
smaller 54 x 54 µm2 area and 5 µm thick z-stack. At the start of electrical stimulation, a 10 Hz stimulation 
train (6 min total, each pulse 200 ms x 180-200 mA) was applied locally to the barrel cortex by a bipolar 
stainless steel electrode using an ISO-Flex stimulus isolator triggered by a Master-8 pulse generator 
(AMPI, Jerusalem, Israel). Quantification of fluorescent changes in destaining puncta was performed as 
described in a previous publication from our laboratory using a custom made Matlab script available from 
our laboratory’s website at http://sulzerlab.org/.41 The kinetics of release were then determined from the 
fluorescent traces using GraphPad Prism 5 by fitting with a single exponential decay function. 
Channelrhodopsin-2 expression, colocalization, and release 
Channelrhodopsin-2 (ChR2) was selectively expressed in noradrenergic neurons using TH-IRES-Cre 
(Jackson Laboratory) animals and a Cre-Lox adenoassociated virus (AAV/2/5.EF1a.DIO.hChR2(H134R)-
EYFP.WPRE.hGH, obtained from Penn Vector) injected into the locus coeruleus (AP: -5.45, ML: +1.30, 
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DV: -3.80) unilaterally as described by our laboratories previously.54 Animals were then allowed to 
recover for 4 wk prior to use in FFN experiments. To measure colocalization in the barrel cortex, FFN270 
was imaged using 760 nm excitation and an emission range of 435-485 nm, and EYFP was imaged using 
950 nm excitation and an emission range of 500-550 nm. Quantification of colocalization between EYFP-
positive axons and FFN270 puncta was conducted as described above and reported as percentage of 
FFN axons that also contain EYFP signal greater than 2 standard deviations above background. 
Stimulation of ChR2 was achieved using a 470 nm LED source (LED4D067 and DC4100 driver, 
Thorlabs) to provide blue light pulses (10 Hz, 5 ms duration, 2,400 pulses total) locally to the brain slice. 
Due to the overlap between FFN270 emission and the ChR2 excitation source, changes in fluorescence 
were measured only before and after stimulation. The before and after image stacks were registered 
using the Correct 3D Drift plug-in (Parslow et al. 2014). For quantification, puncta from the pre-stimulation 
stack were selected using the Multiple Threshold plug-in. The mean fluorescence from puncta of a 
visually continuous axon were then compared to the mean fluorescence post-stimulation. Each FFN270-
positive axon was then grouped based on whether there was colocalization with EYFP signal as 
determined by signal greater than 2 standard deviations above background. Slices from both the injected 
and non-injected brain hemispheres were used for analysis. 
AMPH release in acute brain slice 
To measure changes in FFN270 following AMPH treatment, acute brain slices containing the barrel 
cortex were prepared and loaded with FFN270 as described above. 20 µm thick z-stacks were imaged 
every 60 s for 15 min total. AMPH (10 µM) was added to the ACSF and then perfused over the slice 
starting at 5 min. These z-stacks were then registered using the Correct 3D Drift plugin and the AMPH-
dependent fluorescent changes were quantified by both the number of puncta selected by the Multiple 
Threshold plug-in and the average fluorescent intensity of those puncta over time. 
 
FFN270 Loading and Release in vivo 
FFN270 loading in vivo 
Mice were anesthetized with isoflurane (1-4%). The depth of anesthesia was monitored by both the 
animal’s response to toe-pinch every 5 min and observation of respiratory rate.  Once the proper depth of 
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anesthesia was reached, the animal was placed in a small animal stereotactic apparatus on top of a 
heating pad and Puralube vet ointment was applied to the eyes to prevent vision loss. All surgical 
procedures were performed in a sterile manner. Marcaine (0.5%) with saline 1:2 (0.25%) (2 mg/kg), was 
injected subcutaneously along the midline of the scalp as a local anesthetic. Before the incision, the hair 
over the scalp area was removed with NAIR and sterilized with a gentle scrub with Betadine on a sterile 
cotton swab, followed by 70% ethanol, repeated 3 times. The scalp was then removed with surgical 
scissors, membranes over the skull were removed by scraping, and the exposed bone was dried with 
compressed air. A 3 mm cranial imaging window was then made over the barrel cortex with a high speed 
dental drill (Midwest Stylus 360). The meninges were inspected to make sure there was no damage. Any 
bleeding from the bone was stopped with an application of collagen foam (Avitene Ultrafoam, Bard 
Davol). A glass pipette attached to a Nanoject II (Drummond Scientific) was filled with a 1 mM solution of 
FFN270 diluted in ACSF and attached to the stereotax.  100 nL of FFN270 was injected into the brain at 
coordinates AP: -0.9 mm to -1.0 mm and ML: 3.0 mm, over several depths (DV: 100 µm, 50µm, and 20 
µm) with 3 minutes of delay per depth. The glass pipette was then withdrawn from the brain and a plastic 
ring was glued around the window with Loctite 454 to hold ACSF for imaging. A metal headmount was 
then glued to the nearby exposed bone with Loctite 454. The mouse was then injected with ketamine 
(100 mg/kg) and xylazine (10 mg/kg) i.p. and then weaned off of isoflurane while making sure to maintain 
depth of anesthesia. The mouse was then headfixed under the multiphoton microscope for imaging. The 
body temperature of the mouse was maintained for the duration of imaging with a heating pad. 
Channelrhodopsin-2 stimulated release in vivo 
ChR2 animal preparation, blue light stimulation parameters, and analysis were conducted as described 
above for acute brain slice experiments. The ChR2-positive animals that were used for ChR2 
colocalization and FFN270 release in brain slice were also used for the in vivo experiments. Due to a 
larger degree of z-shift that was present in vivo, the imaging parameters for this experiment were modified 
slightly to collect from a larger z-stack (30 µm, 1 µm/image), while all other imaging parameters remained 
the same. The noradrenergic projections of the barrel cortex were then locally stimulated 35 min post 
FFN270 injection (waited 30 min after initial injection to allow NET-dependent accumulation and natural 
clearance of unloaded FFN270 probe from background tissue, followed by 2 pre-stimulation image 
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stacks). For these experiments, cranial windows were only created on the same hemisphere as the viral 
injection, and the data from both the ChR2-positive and -negative populations came from the same 
hemisphere.  
AMPH induced FFN270 release in vivo 
For AMPH experiments, after FFN270 was loaded, 30 µm z-stacks were collected every 5 min starting 
from 30 min post-FFN270 injection. After 2 image stacks, AMPH (0, 1, or 10 mg/kg) in Dulbecco's 
phosphate-buffered saline was injected into the intraperitoneal cavity. Images stacks were collected for 
30 min post-injection. These stacks were registered using the Correct 3D Drift plug-in, and then puncta 
were selected using the Multiple Threshold plug-in using ImageJ. For the z-planes that remained 
consistent across the entire time course, the number of identified puncta were compared for each time 
point and normalized to the z-stack collected just before AMPH injection. 
 
Statistics 
Data is presented as mean ± SEM and standard parametric tests were used for statistical analysis. For 
the comparison of two different conditions a two-tailed t-test was used, while a one-way ANOVA was 
used for comparing conditions of three or more. A two-way ANOVA was used to compare changes 
between two different traces over time. The sample size was chosen based on similar studies in the field 
and based on our previous studies, the exact sample size for each result is incorporated in the text. To 
determine the normality of a particular distribution we used the D-Agostino & Pearson test. Data collection 
and analysis were not randomized or performed blind to the conditions of the experiments. 
 
RESULTS 
Design, lead identification, synthesis, and photophysical properties of NE-FFNs.   
We approached the global design of NE-FFN probes by incorporating the key structural feature of 
NE, the arylethylamine fragment, into the coumarin fluorophore (Fig. 1A). We chose this design as the 
FFN probe must act as a substrate of both NET on the plasma membrane of NE neurons and VMAT2 on 
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the NE synaptic vesicles. Selective binding of these compounds to their protein targets is not sufficient; 
they need to be actively transported like the native neurotransmitter across the plasma and vesicular 
membrane via ion gradient-coupled processes. Thus, a major portion of the structural space of molecular 
fluorophores was not applicable owing to their large size. The relatively small coumarins, however, 
proved excellent fluorophores for this purpose due to their high brightness-to-size ratio, photostability, and 
biocompatibility. Aided by the relative substrate permissiveness of NET (Rothman 2003, Bonisch et al. 
1999, Rorres et al. 2003), we pursued the discovery of coumarin-based NET substrates.   
Lead identification was initiated by examining the DA-FFNs, FFN102 and FFN202, which have 
been successfully used to study dopaminergic projections in the striatum of acute murine brain slices 
(Rodriguez et al. 2013). To test the applicability of FFNs in vivo, the compounds were applied (50 µM, 30 
min) to the frontal cortex of mice through exposed cranial windows. Whereas FFN102 showed no 
appreciable uptake above background, we observed numerous punctate axonal strands with FFN202 
(Supplementary Fig. S2). Since FFN102 did not label these same axons, we hypothesized that they did 
not express DAT, but instead the closely related NET, and thus represented NE axons. Indeed, NET 
activity of FFN202 was confirmed using human embryonic kidney cells stably transfected with human 
NET (hNET-HEK). Further, the simpler analog 201, sharing the 3-aminoethyl core of FFN202, was 
identified as an excellent substrate for NET (Fig. 6E). Despite its favorable transporter properties at NET, 
201 is not a well-suited fluorescent probe for brain tissue, due to its insufficient brightness and due to the 
pKa of the phenolic group (pKa = 8.0) being outside of the desired physiological pH range to allow 
distinction between localization in the vesicles (pH 5.5) and the extracellular space (pH 7.4). Both 
limitations can be addressed by introducing an electron-withdrawing group in the adjacent position to the 
coumarin phenol, thus providing the rationale for the development of a series of related, halogen-
substituted coumarins.  
Synthesis of this library of fluorophores with desirable photophysical properties and phenol pKa 
values was accomplished with a 5-step synthetic sequence using 2- and 4-haloresorcinols as 
commercially available starting materials (Fig. 6D). The presence of an electron-withdrawing chlorine or 
fluorine atom in the 6- and 8- position (Fig. 6E) increased acidity of the phenolic group (pKa = 5.9 – 6.3) 
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and shifted the pKa to the desired physiologically relevant pH range (5.5-7.4, Supplementary Table S1). 
At the cytosolic pH of ~ 7.4, the haloanalogs are mostly in a phenolate form, which is considerably 
brighter than the protonated phenol form. As a result of this acidification, all newly prepared FFN 
candidates bearing a halogen atom displayed greater brightness than FFN201 (pKa = 8.0). These 
compounds, including FFN270, exhibit two resolved absorption/excitation maxima depending on solvent 
pH (FFN270 ex: 320 nm or 365 nm, em: 475 nm, Supplementary Fig. S1) and thus can function as 
ratiometric fluorescent pH-sensors. 
Development of fluorescent coumarin substrates of NE transporter 
 The collection of 7-hydroxycoumarin compounds (Fig. 6E) was examined for possible NET 
substrates using a multi-well fluorometric assay to measure NET-dependent uptake in hNET-HEK cells. 
The cells were grown in 96-well plates and incubated with the experimental compounds (5 µM, 30 min) in 
the absence and presence of the NET inhibitor, nomifensine (2 µM). The activity of the compounds at 
NET was determined by comparing the fluorescence intensity between the uninhibited wells (signal S; 
NET-dependent and independent/nonspecific uptake) and the inhibited wells (basal signal B; only NET-
independent/non-specific uptake) and expressed as a signal-to-basal ratio (S/B) (Fig. 6F).  
 The 4-series hydroxycoumarin fluorophores (bearing the aminoethyl group in the 4-position of 
coumarin), including the dopaminergic tracer FFN102 (Rodriguez et al. 2013, Pereira et al. 2016, Lee et 
al. 2010), showed insignificant activity at NET; whereas 201, the parent compound of 3-series 
regioisomers, showed robust transporter-dependent fluorescence accumulation (~ 10-fold S/B, Fig. 6). 
Introducing the fluorine atom in position 6 of the 3-series coumarin ring, affording compound 093, 
improved the photophysical properties, but negatively affected the ability of the fluorophore to act as a 
substrate for NET. Increasing size of the halogen atom in this position caused a further decrease in NET 
activity (H (201) > F (093) > Cl (FFN202)), with FFN202 showing only weak NET uptake (< 2-fold S/B). In 
contrast, placing the fluorine atom in position 8, generating FFN270, led to a small reduction in specific 
uptake (8.5 ± 0.4) compared with the lead compound 201 (9.9 ± 0.4, n = 3, p = 0.04, Fig. 6F), while still 
improving photophysical properties (pKa = 6.25). However, additional increase in size of the halogen atom 
at position 8 eliminated NET activity (269, < 2-fold S/B). 
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 To confirm the hNET substrate activity of FFN270 demonstrated in the fluorometric study, we 
used epifluorescence microscopy to visually compare cellular uptake and labeling morphology of 
uninhibited and inhibited hNET-HEK cells using nomifensine (2 µM) or cocaine (1 µM), as well as control 
HEK293 cells. In hNET-transfected cells, FFN270 exhibited a homogeneous staining pattern indicative of 
cytosolic distribution (Fig. 6G), while only negligible uptake was found in nomifensine treated (Fig. 6H), 
cocaine treated (Supplementary Fig. S3), and null-transfected cells (Supplementary Fig. S3), confirming 
the NET-dependent uptake identified from the initial screen. We also examined hDAT and hSERT-
transfected HEK cells, and found that FFN270 is selective for hNET (Supplementary Fig. S4) 
 
.FFN270 is also a substrate of the Vesicular Monoamine Transporter-2 
 To determine the potential of FFN270 to load NE synaptic vesicles and therefore trace NE 
neurotransmission, we examined VMAT2-dependent transport using a protocol employing HEK cells 
stably transfected with rat VMAT2 (VMAT2-HEK). This system, where VMAT2 is expressed and active on 
acidic intracellular organelles of HEK cells, has been employed extensively by our laboratories. (Adam, 
Edwards, & Schuldiner, 2008; Hu et al., 2013; Lee, Gubernator, Sulzer, & Sames, 2010) VMAT2 activity 
was evaluated using wide-field epifluorescence microscopy, which enables visualization of individual cells 
and the intracellular distribution of the fluorescent compounds (Fig. 7C-F). In comparison to NET-HEK 
cells, these cells do not over-express NET on the plasma membrane, and as a result, higher 
concentrations of the probe (20 µM) and longer incubation times (2 h) are used in this experiment to 
facilitate passive diffusion. 
VMAT2-HEK cells that were treated with FFN270 displayed a bright punctate fluorescent pattern 
consistent with accumulation of the compound in acidic organelles expressing VMAT2 (Fig. 7C). This 
VMAT2-dependent accumulation was expressed as normalized total puncta fluorescence (number of 
puncta multiplied by average puncta fluorescence intensity, Fig. 7A). In contrast, only general cytosolic 
fluorescence was observed in the null-transfected HEK cell line (not expressing VMAT2, Fig. 7F) or in 
VMAT2-HEK cells pretreated with a VMAT inhibitor, either dTBZ (2 M, Fig. 2D) or reserpine (2 M, Fig. 
7E). Comparing the VMAT2-uptake of FFN270 with FFN102, a previously confirmed VMAT2 substrate 
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used to measure DA vesicular exocytosis ex vivo (Lee et al. 2010), confirmed that FFN270 accumulated 
in acidic organelles in a VMAT2-dependent manner with similarly normalized intensity (n = 4, p = 0.26, 
Fig. 7A), indicating that this probe is a dual NET-VMAT2 substrate.  
 
FFN270 labels NE neuronal soma and axons in murine brain tissue ex vivo 
 After reaching the in vitro criteria of an NE-FFN – including dual transporter substrate activity 
(NET and VMAT2), favorable photophysical properties (sufficient brightness and phenol pKa within vesicle 
physiological pH range), and low basal cellular labeling – we examined whether FFN270 is suitable for 
labeling neurons by applying the probe to the LC region of acute mouse brain slices (Fig. 8), the primary 
region for noradrenergic cell bodies in the brain. Using a mouse line expressing green fluorescent protein 
(GFP) under the tyrosine hydroxylase promoter (TH-GFP) (Matsushita et al. 2002), GFP is expressed in 
catecholamine neurons, and can be used as a reference marker for noradrenergic neurons in the LC, 
since this region does not contain dopaminergic cell bodies (Ungerstedt 1971). We observed that 72% of 
noradrenergic cells expressing GFP were also labeled with FFN270 (greater than 2x SD of the 
background, 62/86 cells, 6 animals, Fig. 8B-D), while previous generation DA-FFN probes, such as 
FFN102, showed no measurable uptake by any GFP-labeled cells in this region (Fig. 8E-G). 
 We next determined the degree to which FFN270 labels the projections of these noradrenergic 
cell bodies by measuring uptake in the outer layers (Layer 1-3) of the barrel cortex (Fig. 9A). This brain 
region receives extensive noradrenergic innervation (Robertson et al. 2013), and NE-dependent 
neuromodulation has been shown to affect the strength and temporal patterns of sensory input-activated 
barrel cortical networks (Devilbiss and Waterhouse 2004, Constantinople and Bruno 2011, Motaghi et al. 
2006). After FFN270 incubation in acute brain slice, we observed significant staining of noradrenergic 
axons, as well as some blood vessels (Fig. 9B). Due to the relatively sparse density of labeled 
projections, the representative 2D images shown are maximum Z-projections of 20 μm thick volumes. 
Consistent with observations in the LC, FFN102 did not label these cortical noradrenergic projections 
(Fig. 9C), and as predicted by preliminary in vivo results, FFN202 showed minor uptake (Supplementary 
Fig. S5). FFN270 loading of these structures was inhibited with nomifensine (2 μM), or the selective NET 
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inhibitor reboxetine (500 nM, Fig. 4D and E), indicating that NET-dependent transport was required for 
FFN270 uptake into these projections. This inhibition of uptake was quantified by comparing the number 
of puncta in the presence of nomifensine (11%, n = 3, p = 0.004) or reboxetine (24%, n = 3, p = 0.007, 
Fig. 9F) to untreated slices.  
We further confirmed that the FFN270-labeled projections in the barrel cortex were noradrenergic 
using TH-GFP animals as a fluorescent marker. We observed significant axonal colocalization between 
GFP and FFN270 (88.9%, 154/176 axons, 4 animals, Fig. 9G-I). We quantified colocalization by 
measuring the fraction of GFP-labeled axons that also contained significant FFN labeling (> 2x SD of 
background). Unlike the LC, however, there is potentially some dopaminergic innervation in this area 
(Gurevich and Joyce 2000), and GFP in this transgenic mouse line does not distinguish between 
dopaminergic and noradrenergic projections. Consequently, we examined colocalization in TH-Cre 
animals that were injected only in the LC with a virus that expresses the fluorescent marker, enhanced 
yellow fluorescent protein (EYFP) in the presence of Cre recombinase 
(AAV/2/5.EF1a.DIO.hChR2(H134R)-EYFP.WPRE.hGH, Supplementary Fig. S6) (Kempadoo et al. 2016). 
In these animals, we observed substantial EYFP expression in cortical noradrenergic projections of the 
barrel cortex, and a high degree of colocalization between the fluorescent marker and FFN270 (72.4%, 
92/127, 6 animals, Fig. 10C-E). The fraction of FFN projections that do not contain EYFP is consistent 
with our TH-GFP colocalization when accounting for our measured viral transduction efficiency (90-
96%),54 indicating less than 10% of FFN270-labeled axons could be dopaminergic. 
FFN270 reveals NE axonal release sites and their functional heterogeneity 
We next examined whether the punctate fluorescence in the noradrenergic axons represented 
the uptake and storage of FFN270 in synaptic vesicles, and whether FFN270 could be released using 
electrical and channelrhodopsin-mediated stimulation techniques. Using electrical stimulation (10 Hz, 
3,000 pulses), we observed a single exponential decay in background-subtracted puncta fluorescence 
over time with a half-life of 34.6 s, a significant increase in FFN release when compared to the non-
stimulated control slices (Fig. 10A, 2-3 slices per animal, 3 animals). The rate of FFN270 release from 
puncta was comparable to the release rate observed with other FFNs in dopaminergic synapses.41 
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Repeating the electrical stimulation while inhibiting calcium channels using Cd2+ (200 M) led to a 92% 
reduction in the number of identified destaining puncta, confirming that FFN270 release was due to 
calcium-dependent stimulated vesicle exocytosis (2-3 slices per animal, 3 animals).  
Using a complementary optogenetic system in which mice unilaterally express channelrhodopsin-
2 (ChR2) and EYFP in noradrenergic neurons (viral delivery as described above), we also measured 
activity-dependent FFN270 vesicular release triggered by 470 nm light stimulation (10 Hz, 2,400 pulses). 
As local ChR2 activation selectively excites noradrenergic axons, these results exclude potential local 
circuit effects that may result from electrical stimulation of the acute brain slice. Since the FFN emission 
wavelength overlaps with the stimulation light, we could not monitor FFN fluorescence during the stimuli, 
and therefore measured fluorescence before and after. We compared the change in fluorescence of 
individual FFN-labeled axons that colocalized with the ChR2-EYFP signal (ChR+) to axons that did not 
express ChR2-EYFP (ChR–). In the absence of ChR, there was a baseline 27.6 ± 3.3% loss in 
fluorescence after 4 min of stimulation. In puncta with ChR, the loss in fluorescence was 57.4 ± 5.9%, a 
2.1-fold increase (2-3 slices per animal, 5 animals, p < 0.0001, Fig. 5C-F).  
We also compared the FFN release between individual NE axons within the ChR+ and ChR– 
populations.  FFN destaining from the noradrenergic axon population of the ChR– group fit a normal 
distribution (D-Agostino & Pearson test, p = 0.3), but the ChR+ group did not (p = 0.003, Fig. 5G). As 
reported with dopaminergic FFNs,41 by tracing neurotransmitter release with single synapse resolution, a 
trend of low releasing or “silent” presynaptic sites and a separate high releasing population was apparent. 
The fluorescent changes of the ChR+ group were well fit by the sum of two normal distributions with 
distinct peaks (R2 = 0.91). While some of the ChR2+ axons (34%) only released 15.1 ± 2.2% of their 
fluorescent content, the majority of axons (66%) almost fully destained, releasing 75.4 ± 10.9% (Fig. 5G). 
We confirmed this is not an artifact of particular acute brain slices by repeating the normality test on the 
same ChR+ axons grouped by slice and observed a normal distribution between slices (p = 0.2).  
To examine the axons with remaining FFN signal post-electrical or optogenetic stimulation, we 
then exposed slices to AMPH (10 µM), which produced a nearly complete loss of puncta after 5 min (90.8 
± 3.2%, 2-3 slices per animal, 3 animals, Supplementary Fig. S7), suggesting that the remaining 
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fluorescence in these “silent” boutons was located in healthy noradrenergic axons that express functional 
NET and/or VMAT2 and can undergo AMPH-induced reverse transport. The remaining 9.2% of puncta 
that did not destain after the entire time course likely represented the nonspecific signal of FFN270 in 
acute brain slices, and were comparable to the number of puncta that remained in slice after inhibition 
with nomifensine (7.2 ± 0.7%). 
Together, the results in acute mouse brain slices confirm that FFN270 is actively accumulated 
into noradrenergic synaptic vesicles and provides the first probe capable of quantifying noradrenergic 
synaptic release with single synapse resolution in brain tissue, and the first insight into functional 
properties of NE synapses in CNS. 
FFN270 is an optical tracer of NE in vivo  
 We next used two-photon imaging of the superficial cortical layers through a cranial window to 
characterize the potential of FFN270 to study noradrenergic axons in the brain of living animals. For in 
vivo experiments, an imaging window in the skull over the barrel cortex was created, and FFN270 (100 
pmol) was injected through the window into the anesthetized animal at depths from 100 to 20 μm from the 
surface of the brain. In contrast to our original in vivo FFN lead, FFN202, we observed a dramatically 
increased number of FFN-labeled axons using FFN270, with a better signal to background fluorescence 
ratio that persisted over 2 hours (Fig. 11). 
 We found that FFN270 could be used to study evoked NE release in vivo using the virally 
expressed ChR2 system described above (Fig. 11D-F). We measured the change in FFN fluorescence of 
loaded axons before and after 470 nm light stimulation (10 Hz, 2,400 pulses), and compared the changes 
observed in axons that did (ChR+) and did not (ChR–) colocalize with the ChR2-EYFP signal. We 
observed a 2.5-fold increase in the amount of released FFN from ChR+ axons (46.2 ± 8.3%) compared to 
ChR– axons (18.13 ± 4.8%, n = 6 different animals, p = 0.006, Fig. 11C). With FFN270 we could clearly 
distinguish the differences in firing rates between noradrenergic axons undergoing the slow tonic firing 
observed in anesthetized animals (Aston-Jones and Bloom 1981), and those that were optogenetically 
stimulated. In the living animal we also observed differences in the distribution of FFN release from 
individual axons with and without ChR2. The ChR– population was well fit by a normal distribution (D-
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Agostino & Pearson, p = 0.38) while the ChR+ population did not (p = 0.002), suggesting that axons with 
ChR2 can possess different release properties in vivo. In contrast to results in the brain slice, however, 
we were unable to fit the in vivo ChR+ axons to a double Gaussian with well-defined low and high 
releasing populations. This may be due to differences and added difficulties of imaging discrete structures 
in vivo, combine with the limitations of only collecting before and after images when using a blue light 
activated ChR. Alternative stimulation techniques or red-shifted ChRs provide potentially improved 
approaches for measuring FFN release concurrently with noradrenergic excitation. 
 We then used FFN270 to examine the effect of acute AMPH treatment on the noradrenergic 
system of a living mammal. While AMPH is currently used to treat ADHD in hundreds of thousands of 
patients (and abused by millions of people), there is a debate on how AMPH treatment affects individual 
noradrenergic projections in the cortex ( Berridge and Stalnaker 2002, Blanc et al. 1994). Using the same 
in vivo FFN270 loading and imaging technique, we measured changes in FFN content during two AMPH 
treatments (1 and 10 mg/kg) administered through intraperitoneal injection (i.p.) (Salahpour et al. 2008). 
Over 25 min, we observed significantly more FFN released in each AMPH condition compared to saline-
injected controls (Fig. 12). After 5 min, we observed decreases of 63.2 ± 9.9% (1 mg/kg, n = 6 different 
animals) and 81.4 ± 5.2% (10 mg/kg, n = 5 different animals) in the number of FFN-positive structures 
after AMPH treatment, compared to 12.2 ± 7.3% for saline injected controls (n = 7 different animals, p < 
0.001 for both AMPH treatments, Fig. 12D). After 15 min, AMPH-induced FFN270 destaining was largely 







Figure 6. Design of NE-FFNs. A) Design of NE-FFNs combines structural features of NE with the coumarin 
fluorescent core. B) NE-FFNs trace NE uptake from the extracellular space, packaging into vesicles, and 
exocytosis as they are designed to be substrates of NET and VMAT2. C) Representative illustration of NE 
neuron distribution in the brain (Allen Brain Atlas). Neurons originate from the locus coeruleus (LC) and 
project to the majority of brain regions. D) General synthetic scheme for preparation of 3- and 4-series 
aminoethyl-7-hydroxycoumarins as potential NE-FFN candidates. See Methods for experimental conditions. 
E) Library of candidate NE-FFNs. F) Total cellular fluorescence after loading of candidates (5 µM) in hNET-
HEK cells. Signal to Basal ratio (S/B) was determined by comparing FFN fluorescence in the presence and 
absence of 2 µM nomifensine after a 30 min incubation period. Highlighted in blue are the previously described 
DA-FFNs, and in magenta is FFN270, the leading pH-sensitive NE-FFN candidate (S/B: 8.5 ± 0.4, n = 3). 
Representative images of FFN270 without inhibitor (G) and with inhibitor (H). Scale bar: 20 µm. (work by 






Figure 7. FFN270 is a VMAT2 substrate. A) VMAT2-dependent loading of FFN102 and FFN270 were compared 
using the normalized intensity of puncta (number of puncta multiplied by average fluorescence intensity) in VMAT2-
HEK cells after a 2h incubation (20µM) under different conditions. B) Representative schematic depicting the 
rationale for intracellular punctate fluorescence with active VMAT2, and general cytosolic labeling in null-transfected 
or inhibited conditions. The probes passively diffuse through the plasma membrane were they are then actively 
concentrated in acidic compartments only when there is active VMAT2. Without active VMAT2 (inhibition or null-
transfected) intracellular fluorescence is only resultant from equilibrative passive diffusion. Representative images of 
FFN270 in (C) VMAT2-HEK cells, (D) dTBZ (2 µM) inhibited or (E) reserpine (2 µM) inhibited VMAT2-HEK 





Figure 8. FFN270, but not FFN102, labels noradrenergic neurons in the locus coeruleus (LC). A) Atlas image 
highlighting in red the location of the LC in the mouse brain (Bregma: -5.5mm, Allen Brain Atlas). B-D) FFN270 
(B) strongly colocalized with the noradrenergic label TH-GFP (C), resulting in a 72% colocalization of 
noradrenergic cell bodies (labeled by red arrows, 62/86 cells, 6 animals). Cells that did not colocalize are 
highlighted with a blue arrow, and blood vessels are highlighted with a yellow arrow. E-G) When repeated with 
FFN102 (E), no colocalization was observed with TH-GFP (F). Images obtained by 2-photon microscopy in acute 





Figure 9. FFN270 is located in NE axons of the barrel cortex. Representative images FFN270 (B) and FFN102 
(C) loaded into layer 1 of the barrel cortex (A, Bregma: -1.0 mm, Allen Brain Atlas) of acute murine brain slices 
(10 µM, 30 min, 20 µm Z-projections, 2-photon microscopy images). Expected noradrenergic axons appeared as 
long strings with punctated release sites, while blood vessels appeared as wider tube structures. FFN270 axonal 
labeling in Layer 1 of the barrel cortex could be inhibited with nomifensine (D, 2 µM, Nom.) or reboxetine (E, 500 
nM, Rebox.). F) The average number of puncta was significantly higher in control conditions (68.5 ± 22) compared 
to Nom. (7.7 ± 0.7) and Rebox. (17.5 ± 3.5) conditions (one-way ANOVA Bonferroni test, n = 3, average of 2 
slices per condition from 3 different animals). Blood vessel labeling was not inhibited. G-I) FFN270 (G) labeling 









Figure 10. Axonal FFN270 release under electrical and optogenetic stimulation reveals two populations of 
NE release sites in the cortex. A) Change in FFN270 puncta fluorescence in the barrel cortex of acute slice during 
the course of a locally applied electrical stimulation (10 Hz, 3000 pulses, starts at t: 0 min). In red are destaining 
puncta identified during electrical stimulation (t
1/2
: 34.6 s), and in blue are puncta during no stimulation (n = 2-3 
slices per animal, 3 animals for each condition). B) A representative noradrenergic axon labeled with FFN270 
during electrical stimulation. FFN270 (D) also strongly colocalized with the ChR2-EYFP signal (C, 72.4%, 
92/127, 6 animals) in TH-Cre animals injected with floxed-ChR2-EYFP in the LC. The ChR2 was then locally 
stimulated with 470 nm light (10 Hz, 2400 pulses), and the change in FFN270 signal was measured. F) There was 
a significant decrease in remaining FFN270 signal in axons that colocalized with ChR2-EYFP (ChR+, 42.6 ± 
5.9%) compared with axons that did not (ChR–, 72.4 ± 3.3%, 2-3 slices per animal, 5 animals, p < 0.0001). G) The 
individual axons that comprise the ChR– population follow a normal distribution (D-Agostino & Pearson test, p = 
0.3), while the ChR+ population does not (p = 0.003).  The ChR+ population closely follows a double Gaussian 
distribution (Right panel histogram, R
2
 = 0.91) with high (66%, 0.25% F remaining) and low releasing (34%, 





Figure 11. Examining NE axons and release sites in living animals. 
A) Representative in vivo setup using an anesthetized head-fixed animal 
to image Layer 1 of the barrel cortex with 2-photon microscopy. B) A 
representative 3-D reconstruction of FFN270 labeling (50 µM locally 
applied) in Layer 1 of the barrel cortex in vivo. Scale Bar: 20 µm. C). 
FFN270 loaded into NE axons with ChR2 can be released with local 470 
nm light stimulation (10 Hz, 2,400 pulses). There is a significant increase 
in FFN270 released from axons that colocalize with ChR2 (ChR+, 46.2 ± 
8.3%) compared to axons that do not (ChR–, 18.13 ± 4.8%, n = 6 different 
animals, p = 0.006). Representative images of the ChR2-EYFP signal 
(D), and the FFN270 signal before (E) and after (F) optogenetic 
stimulation. Axons that colocalize and destain and highlighted with red 


















Figure 12. Amphetamine releases FFN270 from cortical NE 
projections in vivo. Representative images of FFN270 in Layer 1 
of the barrel cortex in living mice taken before and 5 min after 
injection of amphetamine (AMPH). The left column includes 
images acquired before i.p. administration of a high dose (10 
mg/kg, A), low dose (1 mg/kg, B) and a vehicle (saline only, C), 
while the right column is post injection. D) Quantification of the 
number of puncta before and after each AMPH condition over a 
25 min time course. After 5 min there was already a significant 
decrease in remaining FFN270 puncta in the high (81.4 ± 5.2%) 
and low (63.2 ± 9.9%) AMPH condition when compared to the 
control (12.2 ± 7.3%, n = 6-7 different animals per condition, p < 
0.001 for both AMPH conditions). Scale Bar: 10 µm. (Work by 




 The introduction of FFN270, the first FFN developed to label noradrenergic synapses, has to our 
knowledge, provided the first tool to image the primary function of synaptic transmission – synaptic 
vesicle exocytosis – in the CNS in vivo. Coupled with electrical and optogenetic stimulation, we were able 
to examine exocytosis-dependent release from NE axonal branches and individual NE release sites in 
murine brain tissue and within the intact cortical circuitry of the living brain. The results revealed 
heterogeneity of neurotransmitter release and identified a population of sites that release only a small 
portion of vesicular content, even after long trains of photonic pulses delivered locally to the cortical NE 
axons. This finding is in accordance with our recent study using FFN200, which demonstrated that a 
portion of dopaminergic puncta in the striatum do not release significant amounts of FFN200 (and thus 
DA) and are therefore functionally “silent.” The present study differs in three major points: 1) we examined 
ensembles of single NE release sites, which originate from a distinct neurochemical cell type (LC-NE 
versus DA neurons); 2) the examined NE release sites are in the barrel cortex (versus DA sites in the 
dorsal striatum); and 3) the NE axon stimulation was achieved by selective targeting of ChR2 and local 
photostimulation (versus local current injection). The presence of synaptic heterogeneity in two distinct 
neuronal populations, in two separate brain regions, and under various stimulation methods, suggests 
that this may be a general phenomenon and raises multiple questions: what mechanism underlies 
differences in presynaptic activity? can the silent sites be activated in behavior? do the silent sites serve 
as reserve pools of synaptic vesicles? These and other fundamental questions can now be addressed in 
specific circuits using the FFN probes and associated imaging methods. 
 We also used FFN270 in vivo to address whether systemic AMPH treatment affects release from 
individual cortical noradrenergic projections, previously not possible with standard microdialysis or 
electrochemical techniques. These experiments show that pharmacologically-relevant levels of AMPH 
(e.g., 1 mg/kg, i.p.), that produce behavioral effects (Daberkow et al. 2013), can drive release from locus 
coeruleus axons in the cortex in vivo. While we are examining a NE-like compound rather than NE itself, 
this approach indicates that AMPH acts as an NE releaser and not simply as a NET blocker, a question 
that has been controversial in understanding the therapeutic effects of this drug in ADHD (Heal et al. 
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2013). As AMPH-induced neurotransmitter redistribution is mostly thought to act via reverse transport 
across uptake transporters rather than synaptic vesicle exocytosis (Sulzer et al. 2005, Sulzer 2011), and 
all FFN270 labeled axonal varicosities were uniformly destained in the cortex both in vivo and ex vivo, our 
findings indicate that even the low releasing sites contain neurotransmitter accumulation transporters and 
competent storage vesicles. 
FFN270 addresses the shortcomings of, and complements the existing methods used for NE 
detection in the brain (Nguyen et al. 2010, Muller et al. 2014, Carlsson et al. 1962, Lindvall and Bjorklund 
1974, Secor and Glass 2004, Hettie et al. 2013). Further, as a chemically targeted molecular agent, 
FFN270 should be applicable in primates and other species not amenable to genetic manipulation 
(Wakayama et al. 2017, Er et al. 2015). However, the probe does not detect the neurotransmitter itself 
and cannot measure the vesicle content of NE versus DA (NE is synthesized from DA in NE neurons) 
(Kempadoo et al. 2016) or the changes of NE concentrations at or near the release sites. We envision 
that the combination of FFNs and cell-based fluorogenic NE sensors (Nguyen et al. 2010, Muller et al. 
2014) or protein-based sensors will provide powerful experimental tools for detailed synaptic-level 
examination of NE release and neurotransmission.  In broad terms, multiplexing FFNs with optical 
techniques that measure receptor activation by neurotransmitters promises means that distinguish 
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SHORT ABSTRACT:  
Piezoelectric surgery has led to improvements in human maxillofacial and dental surgery. We have 
developed a protocol to optimize piezoelectric surgery for cranial window surgery in mice.  
 
LONG ABSTRACT: 
Multiphoton microscopy has been widely adapted for imaging neurons in vivo. Repeated imaging requires 
implantation of a cranial window or repeated thinning of the skull. Cranial window surgery is typically 
performed with a high speed rotary drill, and many investigators find it challenging to prevent the drill from 
damaging the delicate dura and blood vessels. Extensive training and practice is required to remove the 
bone without damage to underlying tissue and thus cranial window surgery can be difficult, time 
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consuming, and produce tissue damage. Piezoelectric surgery, which is extensively used for maxillofacial 
and dental surgery, utilizes ultrasonic vibrations to remove bone without damaging soft tissues. We have 
developed a method applying piezoelectric surgery to improve cranial window surgery in mice in 
preparation for multiphoton imaging.  Comparisons within our lab find that the method is requires less 
surgery time and has a lower average rate of complications due to dural bleeding than cranial window 
surgery with a rotary drill.  
INTRODUCTION: 
Cranial window surgery to prepare rodents for multiphoton imaging in vivo has become an important 
technique in neuroscience. The removal or thinning of bone is necessary to prepare the mouse for optical 
imaging with a multiphoton microscope. This surgery is performed either by completely removing an area 
of bone to expose the underlying dura (Holtmaat et al. 2009), or by thinning a region of bone without full 
removal from the dura (Yang et al. 2010). The thin skull approach may produce less inflammation and 
activation of microglia (Dorand et al. 2014) but provides a shallower depth of imaging, a smaller imaging 
window size (200 µm) and a limited time period during which the window can be imaged due to bone 
regrowth (Holtmaat et al. 2009). The addition of a polished and reinforced glass window (PoRTS) can 
increase the imaging size and imaging period but is difficult to perform (Drew et al. 2010). 
Both current surgeries use a high speed rotary drill to thin or remove the bone from the skull. The thin 
skull technique also uses a scalpel after the drill to further thin the bone (Tang et al. 2010). The PoRTS 
technique requires the extra step of high speed polishing with grit (Drew et al. 2010). In a high speed 
rotary drill, an air powered turbine or electric motor causes the drill bit to spin at a high velocity. As rotary 
drills section both bone and soft tissue, there is a risk of damaging the dura and underlying blood vessels. 
The success of the surgery depends on the skill of the surgeon. In addition to these windows prepared 
with mechanical surgical methods, a chemical method of optically clearing the skull with different 
solutions has been developed (Wang et al. 2012, Yang et al. 2016, Vercellotti 2000). However, since 
piezoelectric surgery is a mechanical method of surgery, our comparisons here will be limited to other 
mechanical methods.  
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 Piezoelectric surgical devices utilize ultrasonic vibrations to break down mineralized bone without 
damaging underlying soft tissue, and thus offer an approach to rapidly thin a large area of bone. In a 
piezoelectric surgical handpiece, the turbine is replaced by a stack of ceramic disks: when current is 
applied, the disks vibrate at ultrasonic frequencies. The vibrations are transferred through the handpiece 
to diamond coated tips to cut through bone without damaging soft tissues, an advantage over rotary drills 
that do not discriminate between tissue types. Piezoelectric surgery was originally developed for use in 
human by Tomaso Vercellotti and has led to improvements in dental and cranio-maxilofacial surgery 
(Vercellotti 2000, Vercellotti and Podesta 2007, Stubinger et al. 2015, Basheer et al. 2017). 
Piezoelectric surgery has been used to create an osteotomy in Wistar rats and was found by magnetic 
resonance imaging (MRI) and histology to produce significantly less damage than a traditional dental drill 
(Pavlikova et al. 2011). The authors concluded that piezoelectric surgery was safe for removing the bone 
near soft brain tissue. Mice, however, have a thinner dura that is more easily damaged, and that study did 
not prepare windows for chronic optical imaging. Chronic imaging requires that blood vessels are not 
damaged and that blood clots do not form under the window. Damage to the dura leads to inflammation 
that causes the window to cloud, and activates microglia and the proliferation of reactive astrocytes. Here 
we have optimized piezoelectric surgery for mice to create both thin skull and full bone removal cranial 
windows suitable for chronic imaging. We compared this surgical technique to cranial window surgeries 
prepared with a high speed rotary drill.  
 
PROTOCOL:  
All procedures involving animals were performed according to the standards set by the Columbia 
University Medical Center Institutional Animal Care and Use Committee (IACUC). Euthanasia was 
performed via cervical dislocation under anesthesia with ketamine 100 mg/kg and xylazine 10 mg/kg 
injected Intraperitonealy. All surgical procedures were performed in a sterile manner (surgeon was 
wearing head cap, face mask, sterile gloves and clean disposable lab coat), and surgical tools were 




1.0 Presurgical steps  
1.1 Autoclave all surgical instruments to ensure sterility.  
1.2 Anesthetize C57bl6 mice with isoflurane (4% for induction and 1.5-2% for surgery). Pinch the hind toe 
every 10 min to ensure proper depth of anesthesia: increase anesthesia if vocalization or hind limb 
retraction is seen.  
1.3 Place the mouse in the stereotaxic frame on a heating pad or calibrated water recirculating blanket 
set to 38°C. 
1.4 Apply veterinary eye lubricant to the eyes to prevent drying. 
1.5 Administer buprenorphine (0.1 mg/kg) subcutaneously to provide presurgical analgesia.  
1.6 Remove the hair over the scalp with a 3 minute application of hair removal gel or by shaving with an 
electric razor.  
1.7 Disinfect the scalp with three alternating applications of chlorhexidine or betadine and 70% ethanol 
using a cotton tipped applicator.  
1.8 Inject 100 µl of bupivacaine diluted 50% in saline under the scalp to provide local anesthesia.   
2.0 Piezoelectic cranial window surgery  
 
2.1 Using autoclaved sterile surgical instruments, remove a 1 cm circle of scalp over the skull by cutting 
with surgical scissors in a circular pattern. Lift the scalp off of the skull exposing the periosteum tissue 
over the bone. 
2.2 Use the tip of forceps to scrape the exposed bone clear of any remaining periosteum tissue: this is 
important to ensure that the dental cement will not fall off later.  
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2.3 Set the piezoelectric surgery unit to vibrate on the lowest setting. Note that higher settings may break 
blood vessels due to intense vibrations.  
2.4 Fix the sterile circular tip to the handpiece. Note: we found the 4 mm circular tip to be well suited for 
our surgeries: the large tip size contributes to the speed of the surgery as the entire window can be 
thinned simultaneously.  
2.5 Fill a 10 ml syringe with ice cold artificial cerebrospinal fluid and hold it in the other hand not holding 
the piezoelectric handpiece.  
2.6 Irrigate the skull by dripping the ACSF from the syringe onto the skull at a rate of 1 ml/min. 
alternatively use a peristaltic pump positioned over the skull to free the use of the other hand. Note 
irrigation with cold ACSF is important to prevent overheating due to the friction from the high frequency 
vibrations.  
2.7 Gently apply the vibrating surgical tip to the skull with a light circular motion (3 circles per 1 sec) and 
thin the bone to the desired depth to perform a thin skull preparation (5 to 10 min). Note we chose to 
make 4 mm windows that were thinned to 20 µm. However, the size of the window will vary with the size 
of the surgical tip, and the thickness of the bone can be adjusted to the desired depth based on the length 
of time spent applying the tip to the skull.  
 
2.8 gently adjust the angle you hold the handpiece and change the angle of the tip as you apply pressure 
to the skull to thin the skull uniformly.  
2.9 To perform a complete bone removal without leaving any thin bone behind, thin the bone until cracks 
are visible around the window area. Then remove the remaining flakes of thin bone with forceps without 
damaging the underlying dura.  
2.10 Soak a 1mm piece of hemostatic collagen foam in cold ACSF. Hold the wet foam with forceps and 




2.11 Use forceps to place a 4 mm glass coverslip laterally over the window that has been thinned into the 
bone.   
2.12 Use the back of a small plastic or wooden cotton tipped applicator to apply approximately 100 µl of 
dental acrylic to the skull to hold the window in place. 
 
3.0 Post surgical care. 
  
3.1 Remove the mouse from the surgical apparatus and place it in a heated cage for recovery. Monitor it 
continuously until it has regained full consciousness (assessed by normal mobility, gait, and behavior).  
 
3.2 Assess the animals twice a day for three days for manifestations of post-surgical pain including 
decreased activity, grooming, or food and water consumption, guarding behavior (e.g. limping or a 
hunched posture) or increased aggression. Do not return the animal to the company of other animals until 
it has fully recovered.  
 
3.3 Administer Buprenorphine (0.05-0.1mg/kg) subcutaneously as an analgesic 8-12 hours after the 
surgery for 3 days. Monitor the area of the window closely following surgery for dehiscence, inflammation, 
and signs of infection. Note: If the animal does not return to baseline feeding and grooming behaviors, 
consult a veterinarian regarding possible interventions or euthanasia.  
 
REPRESENTATIVE RESULTS:  
Before proceeding with piezoelectric surgery, remove any residual periosteum from the skull. Once the 
skull is opaque and smooth (Figure 13a), the surgeon may begin piezoelectric surgery. When removing 
bone with the vibrating piezo tip, it is critical to irrigate the skull with ice cold ACSF. Proper irrigation is 
achieved when the bottom 1 mm of the tip is submerged in ACSF (Figure 13b). Without proper irrigation, 
the bone will overheat and damage the brain. After the skull has been thinned to the desired depth 
chosen by the surgeon, there may be some residual bleeding from blood vessels located in the bone. In 
order to rapidly cease all bleeding, apply a small 1 mm piece of collagen foam soaked in ACSF to the 
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area of the window. Let the collagen sit on the skull for approximately 30 seconds (Figure 13c). After the 
collagen foam is removed, the window will appear translucent, allowing clear visualization of the blood 
vessels in the dura. The dura will be intact without significant bruising. (Figure 13d). If the dura appears 
red and inflamed, it is likely due to broken blood vessels from too much pressure applied to the tip during 
the surgery. To protect the new window and prepare it for chronic imaging, a glass coverslip must be 
placed over the area. A properly applied glass coverslip will gently sit on top of the window and will not 
cause any damage to the area. The glass coverslip must cover the entire window. If the glass coverslip is 
properly applied to the skull, the window will remain translucent under the glass. All of the blood vessels 
in the dura will still be visible (figure 13e). Dental acrylic must be applied around the glass coverslip to 
permanently adhere it to the surface of the skull. The edges of the glass coverslip must also be covered 
in dental acrylic (figure 13f). We found that piezoelectric surgery is typically much faster than a traditional 
cranial window, taking around 10-12 min per surgery (figure 14A). We also found that there were less 
complications due to dura bruising and bleeding as observed by eye (figure 14B). A properly prepared 
window will allow multiphoton imaging of fluorescent indicators in cortical neurons in vivo. We chose to 
image the red calcium indicator JRGECO1a in cell bodies of layer 4 cortical neurons (figure 15A-3B). We 
were able to observe calcium transients in these cell bodies through the window prepared using 
PHASOR.  
 
FIGURE AND TABLE LEGENDS:  
Figure 13. Pictures of PHASOR. a) The skull after it has been properly prepared for PHASOR. All of the 
periosteal tissue has been removed, leaving a smooth and clean surface. b) A representative image of 
PHASOR in progress. The bottom 1 mm of the vibrating surgical tip is submerged in ice cold ACSF. The 
fluid is applied to the skull at a rate of 1 ml/min. A light circular motion is applied to the skull and the bone 
is thinned via ultrasonic vibrations. c) After the skull has been thinned, a 1 mm circular piece of collagen 
foam soaked in cold ACSF is allowed to rest on the window to stop any micro bleeds from the bone. d) A 
successful window with a translucent dura displays  all of the intact blood vessels. There is no visible 
damage or bruising to the surface of the brain. e) A glass coverslip is placed over the window to protect 
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the surface of the brain. f) Dental acrylic is applied to the skull to permanently fix the glass coverslip over 










Figure 14. Comparison of success rate in training for PHASOR or dental drill surgery.   
A) Average time per surgery was lower for PHASOR than dental drill surgeries (p<0.05, two tailed t test) 
n= 30 surgeries per group and average 10 surgeries per surgeon. B) The percentage of successful 







through the objective set to 350X zoom) was higher for PHASOR than dental drill surgeries (n = 30 
surgeries for each group, one tailed z test). Error bars show SD.  
 
 
Figure 15. Multiphoton imaging in vivo through a cranial window thinned with PHASOR.  
A) Calcium transients observed with the red calcium indicator JRGECO1a were imaged in layer 4 
pyramidal neurons in murine motor cortex in vivo. Scale bar, 100 µm. B) The same window but different 
region of layer 4 motor cortex. Scale bar, 30 µm. Headfixed mouse with 3 mm window prepared with 
PHASOR. Imaged with a Prairie Ultima multiphoton microscope, 40x Olympus objective, 1040 nm 
excitation wavelength. 
 




Piezosurgery Touch Mectron 5120062 
Piezosurgery GP model has 
the same settings 
Circular 4mm flat piezosurgery tip (# 
OT11) 
Mectron 3370019 
This tip was ideal for our 
windows but there are many 
other tips of different sizes 
available. 
Stereotax frame Kopf 963   
Mouse adaptor Stoelting 51625   
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Makes it easier to irrigate and 
frees up the other hand to 
provide stability. Irrigation 
can be performed by hand 
with a syringe if necessary. 
Avitene Ultrafoam Bard-Davol 1050020 
Important to stop any minor 
bleeding instantly. 
C&B Metabond Parkell S380 
Much stronger than regular 
dental acrylic. 
Artificial cerebro spinal fluid (ACSF) Tocris 3525  






    
Table 2. Equipment list. 
DISCUSSION:  
Modifications and troubleshooting 
The surgery can be modified by changing the surgical tip. There are many different sizes of tip that can 
be applied to the handpiece. Changing the size or shape of the tip will result in different sized windows. In 
addition to the 4mm tip we also tried a 3mm tip and found it also worked well. Even with irrigation with ice 
cold ACSF, we were not able to get good results with tips that were too narrow (approximately .25 mm) 
due to the concentrated vibrations causing too much heat and burning the bone leading to damage to the 
underlying dura. We have not tried the multitude of other tips that are available, and we anticipate that 
other labs may find new applications for these different tips. While the surgery is relatively straightforward, 
we found that there are several steps that may require troubleshooting. The first is that the vibrating tip 
produces a lot of turbulence in the ACSF, which diminishes visibility and produces difficulty in 
ascertaining bone depth during the bone thinning step of the surgery.  We recommend that if it is too 
difficult to see how thin the bone is, take a break to dry the skull and window by applying a sterile cotton 
swab to the side of the bone. Do not apply the cotton swab directly to the window, since the rough surface 
is damaging to thin bone. After checking the depth, reapply ACSF and continue with the surgery. We also 
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found that if there is damage to the dura, it is usually due to the surgeon putting too much pressure on the 
tip. Holding the handpiece more gently and applying less force will likely fix this problem. If the surgeon is 
forcibly scraping the tip on the bone, it will cause a break in the thin bone and damage the skull. Finally, if 
after thinning the bone, the underlying dura appears bruised , it is likely due to excess heat from the 
vibrations. Increasing the rate of ACSF flow will fix this issue.  
 
Limitations of the technique. The main limitation of PHASOR is that the handpiece can thin the bone, 
but cannot remove all of the bone over the dura,: the diamond coated tip has small rough bumps, and the 
rubbing needed to thin the skull would abrade the dura and cause bleeding if it were used to remove all of 
the bone. Thus, the use of forceps is required to remove the remaining thin layer. While there is ongoing 
debate on whether imaging through a thin skull produces less inflammation and less proliferation of 
microglia and reactive astrocytes, in some cases a window with no bone remaining is preferred, e.g., to 
provide a greater depth of imaging3.  
 
Significance with respect to existing methods 
We have optimized cranial window preparation for multiphoton imaging in mice. PHASOR is, to our 
knowledge, the first application of piezoelectric technique to rodent cranial window surgery for optical 
imaging. We find that the use of piezoelectric surgery in mice shares the advantages of increased speed 
and decreased adverse events also reported in humans (Vercellotti 2000, Vercellotti et al. 2001, 
Vercellotti and Podesta 2007, Stubinger et al. 2015). Utilization of the piezoelectric device resulted in 
faster surgeries (figure 2A) and fewer adverse events of bleeding when compared to a high-speed rotary 
drill (figure 2B). We also found, within our lab, that PHASOR was easier for new surgeons to learn than 
traditional approaches to cranial window surgery. Advantages of speed and ease of use are likely to differ 
among surgeons. Thin skull preparations typically require 30-45 min to thin the bone with a drill and 




We found that in windows prepared with PHASOR we were able to image calcium transients in layer 4 
pyramidal neurons in motor cortex that had been transfected with adeno associated virus encoding the 
calcium indicator JRGECO1a (AAV9.Syn.NES-jRGECO1a.WPRE.SV40, UPENN Vector Core). We also 
found that, compared to a thin skull cranial window prepared with a rotary drill and scalpel, the imaging 
region was larger: while a thin skull prepared with a rotary drill and scalpel has an imaging window of 20 
µm diameter (Yang et al. 2010), with PHASOR we were able to quickly thin an area of 3-4 mm. This is 
similar to the imaging window reported in with PoRTS (Drew et al. 2010). This larger window retains the 
benefit of rapid imaging reported for thin skull windows prepared with a dental drill and scalpel. Moreover, 
the window prepared with PHASOR can be immediately imaged, as opposed to traditional bone removal 
windows that may require weeks to heal before the window can be optimally imaged (Dorand et al. 2014).  
 
Future applications: 
We think this technique can be applied to study alterations in blood flow in the vessels under the dura. An 
important future study is to compare immunoreactivity of PHASOR with other methods of cranial window. 
This would be important in order to properly determine if PHASOR produces less inflammation in 
comparison to existing methods.  
We hope that the piezoelectric surgical technique documented here will allow more labs to perform 
cranial windows and successfully use multiphoton imaging in vivo. 
 
Critical steps 
Make sure your handpiece is set to vibrate on the lowest setting and that the ACSF is being irrigated at a 
constant rate. The ice cold ACSF must be applied constantly or it will heat up and damage the dura. We 
found that ACSF must be applied at a rate of at least 1 ml/min. Either use a syringe held in the hand, or 
use a peristaltic pump, rather than the built in irrigation in the handpiece. The irrigation system in the 





ACKNOWLEDGMENTS:   
Supported by the Brain & Behavior, Parkinson’s and JPB Foundations, R01 MH108186 and R01 
DA07418. F31 fellowship 1F31MH109293-01A1 to S C. 
 
DISCLOSURES:  




THESIS PART 2: OPTICAL EXPERIMENTS IN THE STRIATUM 
CHAPTER 5: GENERAL INTRODUCTION 
OVERVIEW 
In this chapter I will provide a review of the striatum, the main input nuclei in the basal ganglia. In 
subsequent chapters, I will describe the studies I performed on this system. In my first study, I used in 
vivo optical recording techniques to examine the synchrony in the indirect path between the left and right 
striatum during tasks of motor behavior. In a preliminary series of experiments included as an appendix, I 
examined the changes in dorsal striatal direct and indirect path firing rates during tasks of motor learning. 
Finally, I examined the firing rates of direct and indirect path neurons during motor tasks involving 
differential anxiety states.  
The basal ganglia 
The basal ganglia comprise a set of interconnected nuclei in the forebrain of vertebrates that play a 
critical role in modulating important functions including voluntary movement, motivation, reward, learning, 
and emotion. Dysfunction in the basal ganglia has been implicated in numerous diseases including 
Parkinson’s disease, Huntington’s disease, mood disorders, anxiety spectrum disorders, and drug 
addiction.  
The nuclei that make up the basal ganglia include the striatum, globus pallidus, ventral pallidum, 
substantia nigra pars compacta (SNc), ventral tegmental area, subthalamic nuclei, and thalamus 
(Wichmann and DeLong 2016). In humans, the striatum is divided by both spatial location as well as 
function into dorsal and ventral components. The dorsal striatum is further composed of two nuclei, the 
caudate and putamen, which are separated by a series of motor neuron axon terminals termed the 
internal capsule. However, in rodents, the dorsal striatum is mostly homogenous without a clear 
anatomical distinction between the caudate and putamen. The ventral striatum is comprised of the 
nucleus accumbens (which can be further subdivided into the shell and core regions) and the olfactory 
tubercle.  
The anatomy of the striatum 
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The circuitry of the basal ganglia is composed of four distinct cortico-striatal-cortico loops: prefrontal, 
motor, oculomotor, and limbic (Nambu 2008). Different cortical areas associated with each of the four 
loops synapse on the striatum, the main input nucleus of the basal ganglia. The work described in this 
thesis focuses on the motor loop in rodents. The rodent motor loop starts with glutamatergic input from 
the cortical areas, (primary motor (MI), supplementary motor area (SMA), and premotor cortex (PM)), 
which synapse on dendrites of the dorsal lateral somatomotor area of the striatum. Information processed 
in the striatum is passed to the output nuclei of the basal ganglia, the substantia nigra pars reticulata 
(SNr) and globus pallidus interna (GPi) through inhibitory GABAergic synapses. These nuclei form 
inhibitory GABAergic synapse on the thalamus which projects excitatory glutamatergic synapses back to 
cortical motor neurons forming the cortico-striatal-thalamo-cortical loop (Sulzer and Surmeier 2012, 
Obeso et al. 2008, Smith and Villalba 2008). This motor loop synapses in the thalamic ventral lateral 
nucleus (VLo and parvicellular part of the ventral anterior nucleus VApc. (Middleton et al. 2000, Hoover 
and Marshall 1999, Miyachi et al. 2006, Akkal et al. 2007). The thalamus, especially the midline and 
intralaminar nuclei, also sends glutamatergic excitatory inputs back to the striatum (Kreitzer 2009). In 
contrast to the dorsal striatum, the ventral striatum receives glutamatergic input from limbic cortical areas 
and orbitofrontal cortex and projects to the ventral pallidum (Gerfen 1984, Nakano et al. 2000).  
The striatum can be further divided into patch and matrix subcompartments by the neurochemical 
markers expressed throughout the region. Histological stains for mu opioid receptors, substance P, and 
enkephalin have shown a patchy pattern that composes 10% of the striatum. The remaining 90% of the 
striatum and exhibits calbindin, somatostatin, and the cholinergic markers, acetylcholinesterase, and 
choline acetyltransferase, and is termed the matrix (Herkenham and Pert 1981, Graybiel 1986, Graybiel 
and Ragsdale 1978, Gerfen 1984, Gerfen et al. 1987, Moriwaki et al. 1996). DA is supplied to patches 
from specific ventral SNc neurons distinct from the SNc neurons that supply the rest of the dorsal striatum 
(Jimenez-Castellanos and Graybiel 1987, Prensa and Parent 2001).   
While both the dorsal and ventral striatum are modulated by DA, the source of the modulation differs for 
each region. Dopaminergic neurons arising from the ventral tegmental area (VTA) comprise two main 
pathways. Dopaminergic neurons projecting to the cortex form the mesocortical dopaminergic pathway, 
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while dopaminergic neurons projecting to the ventral striatum and limbic areas form the mesolimbic 
pathway. In addition, dopaminergic neurons in the substantia nigra pars compacta project to the dorsal 
striatum and comprise the nigrostriatal dopaminergic pathway (Sulzer and Surmeier 2012).  
The direct and indirect paths of the striatum.  
The striatum is composed of approximately 95% GABAergic spiny projection neurons (SPNs) and 5% 
interneurons. The SPNs can be grouped into two circuits according to anatomic projection targets and 
receptor expression patterns termed the direct and indirect paths (Kreitzer 2009). The direct pathway 
comprises SPNs projecting directly to the GABAergic output nuclei of the basal ganglia, the SNr and the 
Gpi, while the indirect pathway comprises SPNs projecting to the globus pallidus externa (GPe) and 
subthalamic nucleus. The direct path SPNs (dSPNs) express Gs coupled DA D1 receptors and their 
activity results in inhibition of the GABAergic output nuclei of the basal ganglia which releases the 
thalamic motor nuclei from inhibition (Figure 16). The indirect path SPNs (iSPNs) express Gi/o coupled 
DA D2 and adenosine A2A receptors (Obeso et al. 2008, Kravitz and Kreitzer 2012). There is also some 
overlap of D1 and D2 receptors in the same SPNs (Aizman et al. 2000). The iSPNs form inhibitory 
synapses on the GPe, releasing the GPi from inhibition and subsequently inhibiting the thalamic motor 
nuclei. The hyperdirect path comprises a cortico-subthalamo-pallidal path. In this path, cortical motor 
neurons bypass the striatum and project to the subthalamic nucleus where they form excitatory 
glutamatergic synapses. The subthalamic nucleus then projects glutamaterigic synapses to both the GPe 
and the GPi/SNr. The hyperdirect path has been hypothesized to play an important role in motor pattern 
selection (Nambu 2008). Similar to ventral striatum, SPNs in the patches receive input from limbic and 
frontal cortex, while the matrix SPNs receives input from sensorimotor cortex and the thalamus 
(Donoghue and Herkenham 1986, Kincaid and Wilson 1996, Ragsdale and Graybiel 1978).   
 
There are some exceptions to the classic direct and indirect paths. It has been found that in addition to 
the main projections to the GPi/SNR, a portion of dSPNs project axon collaterals to the GPe. However, 
the iSPNs project only to the GPe and do not project collaterals to the GPi/SNR (Wu et al. 2000, Fujiyama 
et al. 2011).  
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Anatomic and electrophysiological analysis shows that rather than comprising two segregated circuits, the 
direct and indirect paths SPNs are composed of heterogeneous subgroups. This heterogeneity is present 
at several levels of the motor loop. At the macrocircuit level, the SPNs can be grouped into 
subpopulations by cortical and thalamic input. The cortical input areas, MI, SMA, and PM, form synapses 
on different groups of direct and indirect SPNs with some overlap. Similarly, a portion of SPNs receive 
reciprocal projections from both the GPe and thalamus (Nambu 2008). The dSPNs receive excitatory 
glutamatergic input from the cortex via cortico-striatal pathway and the thalamus via thalamostriatal 
projecting neurons. The iSPNs receive the majority of the corticostriatal axons from sensorimotor cortex 
(Berretta et al. 1997, Parthasarathy and Graybiel 1997). At the microcircuit level, there is even greater 
diversity within each path. Both the indirect and direct path SPNs form inhibitory collateral synapses: a 
Figure 16. Direct and indirect paths of the striatum. The direct path projects directly from the striatum 
to the GPi/SNR, while the indirect path projects to the GPE before projecting to the GPi/SNr.    
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single SPN in either path may receive thousands of 
axon collaterals from both dSPNs and iSPNs 
(Figure 16) (Taverna et al. 2008). Finally, 5% of the 
striatum is composed of several types of 
interneurons that receive cortical input and form 
synapses on SPNs from both paths (Figure 17). 
Although they comprise a relatively small 
percentage of the total neurons of the striatum, 
some interneurons form synapses on hundreds of 
SPNs, and a single SPN receives input from multiple 
interneurons, further contributing to the 
heterogeneity of the complex striatal microciruitry 
(Kreitzer 2009, Gittis and Kreitzer 2012).  
SPNs of the direct and indirect paths have similar 
electrophysiological properties, which makes them 
difficult to distinguish in either acute slice or in vivo 
(Nambu 2008). A defining characteristic of striatal 
SPN recordings is a transition between up and down 
states. SPNs usually have a hyperpolarized resting 
membrane potential between -90mv to -70mv, that is 
termed the down state. When SPNs fire, they 
depolarize to -60 to -40mv, termed the up state. 
Striatal neurons do not display tonic activity and are 
usually quiet unless stimuli is sufficient to overcome 
their significant resting hyperpolarization in the down 
state and invoke a transition to the up state. 
Because of this firing pattern, SPNs are referred to 
as phasically active neurons (Nambu 2008). The down state hyperpolarized resting membrane potential 
Figure 17. Four types of SPN axon collaterals 
in order of most commonly observed to least 
commonly observed. (A) iSPN to iSPN. (B) 
iSPN to dSPN. (C) dSPN to iSPN. (D) dSPN to 
dSPN. 
Figure 18. Different types of interneurons 
and microcircuit interactions in the 
striatum. [Figure is adapted from Gittis and 
Kreitzer 2012]   
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is largely due to polarizing current from inward rectifying potassium channels (Kirs) (Kita 1984, 
Nisenbaum and Wilson 1995, Mermelstein et al. 1998, Uchimura et al. 1989). Transition between states 
only occurs when glutamatergic input is strong (Blackwell 2003). Depolarization activates fast-inactivating 
Kv4.2 and slow-inactivating KV1.2 potassium channels and inhibits the Kirs (Shen et al. 2004, 2005, 
Surmeier et al. 1989).  
Striatal interneurons  
Four different types of interneurons make up the other 5% of the striatal neuron population. In contrast to 
SPNs, interneurons do not possess dendritic spines. Interneurons can be categorized into two groups 
based on the neurotransmitter they release: GABAergic interneurons, and cholinergic interneurons. The 
GABAergic interneurons can be further divided into three types: 1. Fast spiking (FS) parvalbumin-positive 
(PV+), 2. Low threshold spiking (LTS) somatostatin (SOM+), neuropeptide Y and nitric oxide synthase 
positive, 3 calretinin-positive. Each type of GABAergic interneuron has a characteristic profile.  
FS PV+ interneurons are most dense in the dorsolateral striatum and are excited by direct glutamatergic 
synapses from the cortex and the thalamus. Optogenetic studies have shown that FS interneurons form 
inhibitory synapses on the soma and proximal dendrites of SPNs and other interneurons (Straub et al. 
2016). These interneurons are modulated by DA through excitatory D5 receptors and by acetylcholine 
through excitatory nicotinic receptors. They exhibit high frequency firing rates and short duration spiking 
(Kreitzer 2009). While they only constitute a small portion of the striatum, FS interneurons play an 
important role in regulating striatal output through extensive synapses, In addition to forming multiple 
synapses per SPN, individual interneurons form inhibitory synapses on hundreds of different SPNs and 
mediate feed forward inhibition (Tepper et al. 2004, Tepper et al. 2010). Interestingly, FS interneurons 
form gap junctions with other FS interneurons, enabling high speed transmission of signals and 
modulation of striatal motor output (Hjorth et al. 2009, Kreitzer 2009). 
In a manner similar to FS interneurons, LTS interneurons receive excitatory glutamatergic synapses from 
both cortico-striatal and thalamo-striatal axons, and form inhibitory synapses on SPNs. Recent use of 
optogenetic and multiphoton imaging has shown that LTS interneurons mainly synapse on the distal 
dendritic regions of distant SPNs and other interneurons (Straub et al. 2016). Histological studies of LTS 
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interneurons show that they express somatostatin, neuropeotide Y and nitric oxide synthase (Chesselet 
and Graybiel 1986, Kubota and Kawaguchi 1993, Smith and Parent 1986). In contrast to FS interneurons, 
LTS interneurons receive direct dopaminergic synapses (Hidaka and Totterdell 2001). LTS interneurons 
have a distinct electrophysiologic profile with plateau potentials and low-threshold spikes (Kreitzer 2009), 
and display 3Hz to 7Hz membrane oscillations dependent on calcium currents (Song et al. 2016). Like FS 
interneurons, LTS express excitatory D5 receptors, but express muscarinic M1 and M2 receptors rather 
than nicotinic receptors (Rivera et al. 2002, Ariano and Kenny 1989, Bernard et al.1992 and 1998) 
Calretinin-positive interneurons (CR+ interneurons) are the least studied of the three GABAergic 
interneurons and account for only .5% of all striatal neurons (Tepper et al. 2010, Rymar et al. 2004). 
Immunostaining has so far identified three morphologically different types of CR+ interneuron, however 
the lack of a transgenic CR+ mouse line has limited the study of their electrophysiological profile (Tepper 
et al. 2010). 
Cholinergic interneurons account for about 1% of all striatal neurons (Apicella 2017) and both synapse 
on, and receive synapses from, SPNs (Tanimura et al. 2017, Izzo and Bolam 1988, Bolam 1986). 
Cholinergic interneurons also play a direct role in exciting FS interneurons through nicotinic receptors 
(Koos and Tepper 2002). Recent studies of using Designer Receptors Exclusively Activated by Designer 
Drugs (DREADD) have shown that cholinergic interneurons modulate striatal output and increase 
locomotion (Aldrin-Kirk et al. 2018). Cholinergic interneurons may play a role in the processing of salient 
stimuli and exhibit pauses in tonic activity during cues signaling prediction of reward (Greybiel 1994, 
Morris 2004).  
In contrast to FS and LTS interneurons, excitatory glutamatergic innervation of cholinergic interneurons is 
mostly through the thalamo-striatal path and partially through the cortico-striatal path (Lapper and Bolam 
1992, Thomas et al. 2000). Cholinergic interneurons are tonically active at a rate of 2-10 Hz due to 
hyperpolarization activated cation channels as well as sodium channels (Wilson and Goldberg 2006, 
Bennet et al. 2000). 
Cholinergic interneurons are modulated by both DA through inhibitory high affinity D2 inhibitory receptors 
and through excitatory D5 receptors. D2 receptor signaling results in inhibition of voltage gated sodium 
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channels and hyperpolarization of the cell (Zhang et al. 2017) while D5 activation results in elevated 
cAMP and depolarization of the cell. They are also modulated by opioid peptides through delta opioid 
receptors which has been hypothesized to play a role in predictive learning (Heath et al. 2017). Finally, 
they are modulated by acetylcholine through M2 and M4 muscarinic receptors. The M2 receptor is 
present as an autoreceptor on presynaptic terminals and reduces release of acetylcholine (Hersch et al. 
1994, Yan and Surmeier 1996).   
Cholinergic interneurons also play a role in DA modulation and increase DA release by increasing 
intracellular calcium via ionotropic nicotinic receptors on presynaptic DA terminals (Exley and Cragg 
2008, Cachope et al. 2012) and may play a role in levodopa induced dyskinesia (Aldrin-Kirk et al. 2018, 
Cortes et al. 2017). Cholinergic interneurons can also decrease DA release by binding muscarinic M5 
metabotropic receptors on DA terminals (Foster et al. 2014).  
DA and cannabinoid neuromodulation of the striatum 
DA modulates activity over the entire striatum. DA release sites are usually en passant on the axons, and 
near the dendritic shafts of cortico-striatal glutamatergic synapses (Freund et al. 1984). Tonic levels of DA 
are widely suspected to preferentially bind high affinity D2 receptors. In contrast, DA neuron bursting, as 
occurs in response to salient stimuli, is theorized to activate lower affinity D1 receptors (Nambu 2008).   
DA plays a critical role in SPN up and down state transitions. In the up state, L-type currents are 
enhanced by excitatory D1 receptors (Carter and Sabatini 2004, Surmeier et al. 1995).  
D2 receptors are mainly expressed on iSPNs and have a higher affinity for DA than D1 receptors. In the 
up state, in contrast to D1 receptors, D2 receptors inhibit L-type calcium currents. This results in 
decreased SPN firing (Kreitzer 2009).  
In addition to its role in modulating SPN excitability and state changes, DA also modulates glutamate 
release from both the corticostriatal and thalamostriatal excitatory synapses onto medium spiny neurons. 
The D2 receptor can reduce glutamate release from cortical inputs to SPNs terminals of low activity 
during high frequency stimulation, mostly due to retrograde cannabinoid release (Bamford et al. 2009, Yin 
and Lovinger 2005). This presynaptic change in corticostrital plasticity is termed chronic presynaptic 
68 
 
depression CPD. (Bamford 2008, Storey et al. 2016). These changes selectively inhibit the less active 
corticostriatal terminals, and in this way, DA acts as a high pass filter.  
Through signaling through cannabinoid receptors, endocannabinoids play an important role in modulating 
striatal DA release and striatal plasticity. In the striatum, endocannabinoids are retrograde transmitters 
that mainly act on presynaptic CB1 receptor where they modulate short-term and long-term depression of 
synaptic transmission (Heinbockel et al. 2005). Endocannabinoids are fatty acid neurotransmitters. CB1 
receptors in the dorsal striatum are located on presynaptic corticostriatal and thalamostriatal synapses as 
well as on GABAergic interneurons and SPN collaterals (Lafourcade et al. 2007, Fitzgerald et al. 2012). 
By acting at postsynaptic D2 receptors on SPNs with simultaneous mGluR1 activation, DA drives SPNs to 
release endocanabinoids that bind the cannabinoid receptor CB1 on presynaptic corticostriatal and 
thalamostriatal synapses and induces long term depression LTD (Wong et al. 2015). This form of 
corticostriatal LTD has been implicated in motor learning and action initiation (Jin et al. 2014, Hilario and 
Costa 2008). The cannabinoid system is also activated by Δ9Tetrahydrocannabinol (THC), a psychoactive 
compound in Cannabis sativa (marijuana) plants.  
There has been recent interest in cannabinoid modulating compounds as antiepileptics (Friedman and 
Devinski 2015). Use of Cannabis sativa for seizures is not an entirely new concept, as references to 
cannabis in the treatment of epilepsy goes as far back as ancient Sumeria in 1800 B.C. (Schultes 1973) 
Recent studies have shown that the active antiepileptic compound is cannabidiol ,which is not 
psychoactive, while THC is not thought to play a critical role in seizure suppression (Rosenberg et al. 
2015, Filloux et al. 2015). Additionally, animal models demonstrate cannabidiol efficacy in models of focal 
epilepsy, and it is possible that it may soon join the other broad spectrum antiepileptics as standard of 
care (Devinsky et al. 2017). 
The role of the striatum in motor behavior.  
Several models have been proposed to explain how the direct and indirect paths function to influence 
motor behavior. The classical “go nogo” model, first proposed by Albin and DeLong, postulates that the 
two paths act in opposition to each other (Albin et al. 1989). Activation of the direct path causes 
movement while activation of the indirect path inhibits movement. This hypothesis was originally based on 
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the predicted downstream effects on thalamic motor nuclei of inhibiting the GABAergic output nuclei of 
the direct and indirect paths. This theory arose from studies showing motor deficits resulting from surgical 
lesions of basal ganglia output nuclei in primates. Later support came from observations that a specific 
immunotoxin mediated lesion of the entire indirect path resulted in increases in locomotion (Sano et al. 
2003). In a recent study supporting the classic go nogo interpretation of the paths, optogenetic activation 
of the direct path neurons via channelrhodopsin resulted in increased locomotion while optogenetic 
activation of the indirect path neurons resulted in freezing, bradykinesia, and decreased locomotion 
(Kravitz et al. 2010). However, this study modeled all of the neurons in either the direct or indirect paths 
as a homogenous group, and using optogenetic techniques to put all of the dSPNs or iSPNs in the up 
state overrides the complex signal filtration process that occurs with natural movement. 
In concordance with DeLong’s original studies on behaving primates, a more recent model hypothesizes 
that the direct and indirect SPNs require coordinated and concurrent activity to modulate motor behavior 
(Nambu 2008, Cui et al. 2013, Mink 2003, Chan 2005). In this theory, both the direct and indirect paths 
are active at the same time. The direct pathway supports selection of the intended motor pattern while the 
indirect path simultaneously suppresses competing motor patterns. This theory of the striatum as a 
complex processor, rather than simply two opposing circuits, is supported by anatomic and 
electrophysiological analysis showing that rather than comprising two opposing segregated circuits, the 
direct and indirect paths SPNs form synapses on each other. This model was strongly supported when in 
vivo optical recordings from fiber optic implants in mice expressing the genetically encoded calcium 
indicator GCaMP3 in dSPNs or iSPNs showed that the levels of activity in the direct and indirect path 
SPNs are highest before movement initiation and during movement (Cui et al. 2013). Additionally, activity 
in both paths are lowest during stasis. While this study was able to show general activity, single photon 
counting does not have the optical resolution to record from subpopulations within the direct and indirect 
paths. These findings were confirmed by optogenetic aided electrophysiological recordings, which found 
that both paths were activity during execution of motor patterns, and that individual neurons would fire 
during specific parts of the action sequence (Jin et al. 2014). In a more recent study, Klaus et al. 2017, 
used a GRIN lens implanted in the dorsolateral striatum to record from the dSPNs and iSPNs with high 
spatial and temporal resolution. This technique allowed recording from populations of several hundred 
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neurons that expressed the improved calcium indicator GCaMP6f (Chen et al. 2013). They were able to 
determine that ensembles of SPNs in close spatial proximity are active during specific actions. They also 
found that similar actions recruited overlapping ensembles that were more closely located (Klaus et al. 
2017).   
In addition to glutamatergic input, SPNs also receive GABAergic corticostriatal input from interneurons in 
primary (M1) and secondary (M2) motor cortices (Rock et al. 2016). Optogenetic activation of PV+ in M1 
and SOM+ projecting interneurons in M2 result in inhibition of locomotion while optogenetic activation of 
SOM+ interneurons in M1 results in increased locomotion (Melzer et al. 2017). 
Striatal dysfunction in motor disease.  
Dysfunction in the striatum plays an important role in several motor diseases, the most prevalent of which 
is Parkinson’s disease. Parkinson’s is the second most common neurodegenerative disease after 
Alzheimer’s. and affects over ten million people worldwide, with a combined health burden In the United 
States of over 25 billion dollars. The disease is characterized by the degeneration of the dopaminergic 
projection neurons in the substantia nigra pars compacta (SNc), resulting in a striatal DA deficiency 
(Sulzer and Surmeier 2012, Obeso et al. 2008, Smith and Villalba 2008, Kreitzer and Berke 2011).  This 
DA deficiency causes widespread changes in the complex motor circuitry of the striatum leading to 
characteristic motor symptoms, including bradykinesia (slow and reduced movement and reflexes), 
akinesia (loss of voluntary movement), muscle rigidity and resting tremor (Albin et al. 1989, Hammond et 
al. 2007, Hernandez et al. 2013).  
All striatal neurons express DA receptors, and dopaminergic projection neurons from the SNc play a 
critical modulatory role that is essential to the normal function of all neurons in the motor loop of the 
striatum (Sulzer and Surmeier 2012). In the normal state, the SNc projection neurons have low frequency 
tonic activity and maintain a tonic level of DA that appears to bind high affinity D2 receptors, resulting in 
inhibition of indirect path SPNs.  In response to stimuli, the SNc fires higher frequency bursts, resulting in 
a higher level of striatal DA available to bind lower affinity D1 receptors and increase excitability of the 
direct path SPNs (Kreitzer 2009). In Parkinson’s, loss of DA is thought to result in a pathological over-
excitation of the indirect path and corresponding decrease in excitability of the direct path (Delong and 
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Wichmorann 2009, Hammond et al. 2007, Sulzer and Surmeier 2012, Jaidar et al. 2010). Chronic DA 
depletion also causes pathological changes to the interneurons which further disrupts the microcircuitry 
and normal function of the SPNs (Taverna et al. 2008). The FS interneuron innervation of medium spiny 
neurons doubles leading to abnormal iSPN synchrony (Gittis and Kreitzer 2012). Due to a loss of 
inhibitory DA tone, cholinergic interneurons increase firing and begin to fire in synchronous patterns (Ding 
2008, Raj 2001). Additionally, loss of DA leads to deterioration of the collaterals between SPNs (Taverna 
2008). While the global changes to the striatum in the parkinsonian state have been quantified, it is 
unknown how DA depletion affects the subpopulations of dSPNs and iSPNs (Bevan et al. 2002). 
In contrast to Parkinson’s, Huntington’s disease is characterized by loss of SPNs, with iSPN death more 
prevalent in the early stages (Reiner et al. 1988). This loss of the indirect path leads to hyperkinetic 
movements that characterize the disorder and supports the theory that the indirect path works to 









CHAPTER 6: IN VIVO RECORDING FROM THE DIRECT AND INDIRECT PATHS 
REVEALS INCREASED FIRING IN A MOUSE MODEL OF ANXIETY 
ABSTRACT 
Anxiety disorders are the most common class of mental illness worldwide, costing more than 40 billion 
dollars in the US. Human magnetic resonance imaging studies implicate dysfunction in the striatum and 
increased striatal volume in the pathology of anxiety. The dorsal striatum is largely comprised of spiny 
projection neurons (SPNs) that project through the basal ganglia circuitry in two major pathways, termed 
the direct and indirect paths. Direct pathway SPNs express DA D1 receptors while indirect pathway SPNs 
(iSPNs) express DA D2 receptors. The activity of the dSPNs and iPSNs during tasks of anxiety have 
never been examined in vivo. We hypothesized that these neurons may show differential activation 
depending on the anxiety state of the mouse. 
We used time correlated single photon counting (TCSPC) to record neuronal activity in the dSPNs and 
iSPNs during the elevated plus maze task of anxiety. TCSPC is an in vivo optical recording technique that 
was first applied to neuroscience by Cui et al. 2013. In this technique, a single mode optical fiber is 
implanted in the brain of a mouse. Neurons are then transfected with a viral vector expressing a calcium 
indicator such as GCaMP. A blue laser is pulsed into the brain through the fiber to excite the GCaMP to 
emit green light. This green light travels through the fiber where it is measured by a photo detector. The 
photons measured with this technique can be precisely measured by time. The intensity of the 
fluorescence from GCaMP can be used to determine the degree of neuronal activation and is a proxy for 
neuronal firing rate (Cui et al. 2013). Using transistor transistor logic (TTL) pulses, the recording time 
stamps generated by the TCSPC machine can be matched to video recorded with a high speed camera. 
This allows matching specific mouse behaviors to activation of specific groups of neurons. 
The elevated plus maze, consists of two open and two closed arms. Time spent in the closed arms is 
thought to be associated with a lower anxiety state than the open arms. D1-Cre (direct path) and A2A-Cre 
(indirect path) mice were injected with AAV9.Flex.GCaMP6f virus. Imaging fibers were implanted in the 
dorsal lateral striatum. Mice were recorded with a high speed video camera framelocked to the TCSPC 
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sampling rate. This enabled us to correlate anxiety related behaviors with GCaMP6f changes in 
fluorescence. Both the dSPNs and iSPNs also showed a significantly higher rate of firing the closed arms 
of the maze (P<.05). Utilizing high speed video analysis, we concluded that the increased calcium 
transients in the dSPNs correlated with behaviors that are associated with a lower anxiety state. 
INTRODUCTION 
 
Fear is an acute response of increased arousal and somatic symptoms in the presence of negative 
stimuli, while anxiety occurs in the absence of a proximal threat (Calhoon and Tye 2015). In the proper 
context, both anxiety and fear have potentially useful evolutionary benefits. Increased vigilance, and 
stimulation of the sympathetic nervous system can aid avoidance or escape from danger and lead to 
increased survival of an individual. Excessive, and pathological levels of inappropriate anxiety, however, 
can lead to sever impairment of daily living.  Anxiety disorders, including obsessive compulsive disorder 
(OCD) and generalized anxiety disorder (GAD) are the most common class of mental illness worldwide, 
costing more than 40$ billion in the US and causing significant functional impairment (Andlin-sobocki and 
Wittchen 2005, Hoffman et al. 2008). The DSM-5 symptoms of (GAD) are characterized by excessive and 
difficult to control anxiety or worry about topics events or activities that interfere with daily living. The 
disorder is also associated with several other symptoms such as restlessness, fatigue, difficulty sleeping, 
difficulty concentrating, irritability, somatic symptoms.  
The circuit most studied in anxiety involves two loops. First, threatening stimuli is detected by the sensory 
systems and flows in a forward circular loop between the amygdala, bed nucleus of the stria terminalis 
(BNST), ventral hippocampus (vHPC) and medial prefrontal cortex (mPFC). Then information flows 
through this loop in the reverse direction via reciprocal projections. Importance is assigned to the stimuli 
in the forward loop, and this importance is revaluated in the backwards loop (Allsop et al. 2014, Calhoon 
and Tye 2015). 
In addition to the structures that comprise the anxiety loops, the striatum has also been implicated as 
playing a potential role in anxiety disorders. Dysfunction in the striatum and increased striatal volume on 
human magnetic resonance imaging (MRI) studies has been implicated in the pathology of anxiety. In 
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anxiety disorders, the increased sensitivity to a perceived possibility of future threat to the individual is 
conceptualized as intolerance of uncertainty (IU). Individuals with GAD show increased volume in the 
dorsal striatum (caudate and putamen), as assessed by structural MRI, compared to healthy controls. The 
levels of IU also positively correlate with the increase in volume (Hilbert et al. 2015). A recent meta-
analysis of volex-based morphometry studies found that individuals with OCD and other anxiety disorders 
showed increased bilateral gray matter in the dorsal striatum (caudate) compared to healthy controls. 
However a reduction in matter was seen with individuals with posttraumatic stress disorder and panic 
disorder (Radua et al. 2010). These changes in striatal volume seem to occur on a gradient, and are seen 
even in individuals who have increased anxiety that does not reach pathological levels. Additionally, 
striatal volume assessed with MRI recently showed that in healthy individuals, the volume of the dorsal 
striatum, especially putamen was positivity correlated with increased IU (Kim et al. 2017). In patients with 
OCD refractory to treatment, deep brain stimulation (DBS) of the nucleus accumbens can provide an 
effective but invasive treatment that provides relief from the symptoms (Denys et al. 2010, Gabriels et al. 
2003, Greenberg et al. 2010). Finally, in rat models of anxiety, DBS in both the ventral and dorsal striatum 
was found to reduce anxiety (Dijk et al. 2013).  
The dorsal striatum is largely composed of GABAergic spiny projection neurons. Striatal SPNs comprise 
two major circuits. The SPNs expressing D1 receptors (dSPNs) maintain a direct projection to the 
substantia nigra pars reticulata (SNr) and globus pallidus externa (GPe), termed the direct pathway. 
SPNs expressing D2 receptors (iSPNs) trigger a multisynaptic circuit, synapsing in the globus pallidus 
interna (GPi), which then projects to the SNr /GPe, termed the indirect pathway. Both direct and indirect 
pathway SPN activity are modulated by dopaminergic projections from the SNc. These paths can be 
further divided into the associative and sensorimotor paths depending on their cortical input. The SPNs in 
the dorsal medial striatum (DMS) receive input from the mPFC and cortical association areas and 
comprises the associative path, while the SPNS in the DLS receive cortical input from sensory and motor 
areas and comprise the sensorimotor path.   
Anxiety states can be measured in the mouse through different behavioral paradigms. One of the most 
widely used is the elevated plus maze. In this task, a maze is constructed in the shape of a plus symbol 
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with four rectangular arms of equal length. Two of the arms are surrounded by walls and the other two 
arms are left open. The maze is elevated above the ground. The mouse is placed in the center of the 
maze and is allowed to explore freely for a period of time (usually 5 to 10 minutes). The purpose of this 
task is to evaluate anxiety-like behaviors in mice by observing their motivation to explore the open areas 
of the maze. Since the mouse will naturally avoid the open arms of the maze, the time in the open arms 
can be used as a proxy of the anxiety state of the animal (Walf and Frye 2007). This behavioral paradigm 
has been both genetically and pharmacologically validated. Anxiolytic drugs, used to treat individuals with 
GAD, increase the time spent in the open arms of the maze, while anxiogenic drugs reduce the time in 
the open arms (Pellow et al. 1985, Lister 1987, Shepherd et al. 1994). In addition to the time spent in the 
open and closed arms of the maze, other behaviors like head dipping, grooming, and rearing are 
associated with a lower anxiety state and provide further information regarding the animal’s anxiety state 
(Shepherd et al. 1994, Braun et al. 2011, Heredia et al. 2013). 
In mouse models of anxiety, the striatum has been implicated in behaviors associated with in the elevated 
plus maze. Targeted ablation of PV interneurons in the dorsal striatum, which has been shown to disrupt 
the direct and indirect paths, reduces the time spent in the open arms of the elevated plus maze (Xu et al. 
2016).  Ablation of dopaminergic projections to the dorsal striatum with the neurotoxin MPP+ increases 
anxiety-like behaviors and decreases the time spent in the open arms of in the elevated plus maze 
(Cunha et al. 2017). Despite recordings from hippocampus, prefrontal cortex, and amygdala during the 
elevated plus maze, little is known about the firing patterns of the dorsal striatal direct and indirect path 
neurons during the elevated plus maze (Carvalho et al. 2005). We used time correlated single photon 
counting (TCSPC) to distinguish dSPNs and iSPNs activity in vivo using the genetically encoded calcium 
indicator GCaMP to measure calcium transients, which serves as a proxy of somatodendritic action 
potentials (Chen et al. 2013). Time correlated single photon counting (TCSPC) of fluorescence changes 
in GCaMP has recently been applied to image dSPNs and iSPNs activity in awake behaving healthy mice 
(Cui et al. 2013, Kupferschmidt et al. 2017), but has not yet been applied to study changes that occur in 
behavioral models of anxiety. We hypothesized that the direct and indirect paths of the dorsal striatum 
may show differential firing depending on the anxiety state of the mouse.  
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Because the SPNs of the associative path receive input from cortical association areas involved in the 
main anxiety processing loops such as the mPFC. We chose to record from the dSPNs and iSPNs in the 
DMS. We transfected mice expressing cre recombinase in A2A-receptor-expressing neurons and D1-
receptor expressing neurons with AAV9 Flex GCaMP6f virus into DMS, and implanted imaging fibers in 
the same site using TCSP. Mice were recorded with a high speed video camera framelocked to the 
sampling rate of the time correlated single photon counting machine enabling behaviors to be correlated 
with calcium transient changes with millisecond precision. 
METHODS 
Mice 
Adult 8 week old male D1-Cre (GENSAT FK-150) and A2A-Cre (MMRRC 036158) mice were housed in a 
reverse light cycle room. All behavioral experiments were performed in the dark cycle of the mouse. All 
procedures were conducted in accordance with Institutional Animal Care and Use Committee (IACUC) of 
the New York State Psychiatric Institute.  
Viral injection and fiber implant surgery 
Mice were injected with buprenorphine (0.05- 0.1 mg/kg) prior to anesthesia and anesthetized with 
isoflurane (1-4%). Marcaine diluted 50% in saline was injected under the scalp to provide local anesthetic. 
The body temperature of the mouse was maintained for the duration of imaging with a heating pad. The 
depth of anesthesia was monitored by both the animal’s response to toe-pinch every 5 min and 
observation of respiratory rate.  Once the proper depth of anesthesia was reached, the animal was placed 
in a small animal stereotactic apparatus on top of a heating pad and Puralube vet ointment was applied to 
the eyes to prevent vision loss. All surgical procedures were performed in a sterile manner. Marcaine 
(0.5%) with saline 1:2 (0.25%) (2 mg/kg), was injected subcutaneously along the midline of the scalp as a 
local anesthetic. Before the incision, the hair over the scalp area was removed with NAIR and sterilized 
with a gentle scrub with Betadine on a sterile cotton swab, followed by 70% ethanol, repeated 3 times. 
The scalp was then removed with surgical scissors, membranes over the skull were removed by scraping, 
and the exposed bone was dried with compressed air. A 1 mm hole was then made over the dorsal 
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striatum with a high speed dental drill (Midwest Stylus 360). Any bleeding from the bone or dura was 
stopped with an application of collagen foam (Avitene Ultrafoam, Bard Davol). A glass pipette attached to 
a Nanoject II (Drummond Scientific) was filled with AAV9 Flex GCaMP6f virus (UPENN Viral Core) (300 nl 
of 1013 viral units/ml), and attached to the stereotax. A volume of 300ul of virus was injected into the 
dorsal striatum (1 mm AP, 1.0 mm ML, over several depths (DV: 3.0mm, 2.5 mm, 2,2mm) with 3 minutes 
of delay per depth. The glass pipette was then withdrawn from the brain and an imaging fiber was then 
implanted into the dorsal striatum at the location of the injection (1 mm AP, 1.0 mm ML, 2.5mm DV). The 
fiber was then secured to the skull with dental acrylic (Parkel Metabond). The mouse was then transferred 
to a heated cage to recover.  
Time correlated single photon counting 
To measure neural firing patterns in the two striatal pathways, mice were tethered the TCSPC machine 
(custom built from Becker Hickl parts). GCaMP6f was excited with a 473 nm picosecond pulsed laser 
(Becker Hickl). Mice were tested while freely moving and awake on the selected behavior task while 
GCaMP fluorescence was measured by the TCSPC in a population of neurons within 300 μm of the 
implant. Photon counts were recorded by TCSPC Image software from Becker Hickl.  
Video and photon analysis.  
High speed videos were analyzed and behaviors were scored by hand and annotated onto the recordings 
from the TCSPC machine. The following behaviors in the elevated plus maze were observed to be 
correlated to calcium transient peaks: initiation of forwards movement, initiation of backwards movement, 
initiating rearing, initiating sitting, nose poking, right turns, left turns, walking backwards, grooming, 
moving between the middle zone to the open or closed arms.  
Photon analysis 
Calcium transients were analyzed using custom functions written in MATLAB (Figure 19) by my 




Calculation of dF/F. Raw photon counts were low-pass filtered using a Kaiser window (pass band 40 Hz, 
stop band 44 Hz) and then smoothed by binning the filtered data into 25 msec bins and calculating the 
median of each bin. The background fluorescence at time t in a session of the smoothed photon count, 
B(t), is then calculated by centering a sliding window (width 30 s) and determining the median of the 
photon count within that window. The dF/F at time t is calculated as [photon count at time t – B(t)] / B(t) 
(Howe & Dombeck 2016). For time points at the beginning and the end of the session where a centered 
sliding window is unavailable, the B(t) of the nearest time with a centered window is used to estimate the 
background fluorescence (e.g., for the beginning of the session t = 0-15 s, the B(t) of t = 15 s was used). 
 
Identification dF/F transient blocks. Time bins during which dF/F are significantly elevated above 
baseline levels (i.e., transient blocks) are identified as follows.  
The onset of a transient block. The onset of a transient block is identified by time-bins at which the 1st 
derivative of the dF/F (i.e., the slope) is higher than random chance, which is indicative of the rise of 
calcium transients (Gunaydin et al. 2014, Ramdya et al. 2006). The 1st derivative of the dF/F is calculated 
and then smoothed using a triangular window with half width of 4 bins (100 msec). The sample of 1st 
derivative is assumed to be normally distributed with potential outliers. The mean of this underlying 
normal distribution is estimated using the sample median of the 1st derivative dF/F (robust against 
outliers). The standard deviation (S.D.) is of this underlying normal distribution is estimated using the 
median absolute deviation (also robust against outliers; Gunaydin et al. 2014, Calipari et al. 2016). These 
estimates (mean, S.D.) are then used to calculate the p value of each data point of the 1st derivative dF/F 
(i.e., z-test).  The Benjamini-Hochberg procedure is then used to correct for multiple comparisons (of 
multiple time-bins), with a False Discovery Rate set to 5% (0.05): this allows false positives to be 
controlled for regardless of session length (number of time bins). Finally, a time bin is only deemed 
significant if the next 3 time bins are also significant (after FDR correction), in order to reduce 
unreliable/false positive time bins.  
The offset of a transient block. The criterion for the offset of a transient block is as follows. After the dF/F 
(not its 1st derivative) in a transient block has reached at least one peak (defined below), the first 
subsequent time-bin with a dF/F that either falls below the mean + 0.5×S.D. of the baseline dF/F 
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population up to that time bin (i.e., the population of time bins that are not classified as “transient”) 
(Lovett-Barron et al. 2014, Science 343:857-63), or falls below the dF/F level at the start of the “transient” 
block, is defined as the offset of a transient block. 
 
Identification dF/F peaks. Visual inspection of dF/F traces suggests that within each transient block (i.e., 
a continuous block of time bins during which the dF/F is elevated above baseline levels), there can be 
multiple dF/F peaks. Gross measures of dF/F, such as the average dF/F during transients, obscure both 
the timing of these peaks and their amplitudes. dF/F peaks can be identified by time bins at which both 
the following occur: 1) the 1st derivative of dF/F crosses from positive to negative, 2) the 2nd derivative of 
dF/F is more negative than chance, which indicates that the downturn in dF/F is steeper than chance. 
This second criterion allows inflexion points of dF/F to be excluded. A custom algorithm was used to 
identify dF/F peaks within each transient block, described as follows. For each transient block, the highest 
dF/F within the block is automatically classified as a dF/F peak. Additional putative peaks within each 
transient block are identified by 1) first locating the time-bins at which the 1st derivative of dF/F crosses 
from positive to negative; 2) then examining the dF/F in a time-window of 100 msec before and 100 msec 
after, and locating the time-bin with the maximum dF/F within this time-window; 3) then looking up that 
time-bin’s corresponding 2nd derivative of dF/F, and accept the time-bin as a peak if the 2nd derivative of 
dF/F is significantly negative (calculated as described below). One consequence of this algorithm is that 
the minimal time between two consecutive peaks that can be identified is 125 msec. The 2nd derivative of 
dF/F is calculated from the 1st derivative of dF/F (see “Identification dF/F transient blocks section” above) 
and then smoothed using a rectangular window with a half width of 2 bins (50 msec). The sample of 2nd 
derivative is assumed to be normally distributed with potential outliers, analogous to the sample of 1st 
derivative, and its mean and S.D. were estimated using the sample median and the median absolute 
deviation, respectively (see “Identification dF/F transient blocks section” above). Time bins at which the 
2nd derivative of dF/F is significantly negative is identified by calculating the p-value of each time bin, and 
then using the Benjamini-Hochberg procedure to set the False Discovery Rate to 5% (0.05). A time bin is 
only deemed significant if the next 3 time-bins are also significant (after FDR correction), in order to 
reduce unreliable/false positive time-bins. 
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Elevated plus maze 
The maze was constructed of plastic plates glued together to form 4 arms (two open and two with walls). 
The maze was 30 cm long and 5 cm wide. The open arms of the maze did not have any railing. The maze 
was elevated 30 cm above the floor with plastic legs. In order to avoid detector overload due to 
overexposure of the detector to photons, the behaviors were performed under red light. A 30 fps camera 
(Med Associates) was positioned above the maze and a second camera 240 fps camera was positioned 
perpendicular to the maze. Both cameras were synchronized to start recording at the same time as the 
TCSPC machine. Mice were acclimated to the room for 1 hour prior to recording. Each mouse was taken 
out of its cage and tethered to the TCSPC machine before being placed in the maze facing the same 
open arm. Mice were allowed to explore the maze freely for 10 minutes before being returned to their 
cage.  
RESULTS 
We observed that mice spent significantly more time in the closed arms than in the open or middle areas 
of the maze (Figure 20 top). These results are in accordance with previous studies using the elevated 
maze (Walf and Frye 2013). We found that both direct path (GENSAT FK-150 Cre) and indirect path 
(A2A-Cre MMRRC 036158) mice showed a similar preference for the closed arms, demonstrating the 
effect was consistent across the different genotypes (Figure 20 bottom). Analysis of the rate of calcium 
transients showed that the SPNs of the dorsal striatum exhibited higher activity when the mouse was in 
the closed arms of the mouse than the middle and open arms (Figure 21 top). We then sought to 
determine if the rate of firing in the direct and indirect paths differed with the anxiety state of the mouse. 
We found that both dSPNs and iSPNs demonstrated significantly higher rates of firing in the closed than 
in the open arms (Two way ANOVA P < .001) (Figure 21 bottom).  
We then examined if the increased firing rate was linked to increased motor behavior in the closed arms 
of the maze. The firing rates of dorsal striatal dSPNs and iSPNs, measured with calcium transients, has 
previously been correlated with motor patterns (Cui et al. 2013). Additionally, behaviors in the maze are 
associated with the anxiety state of the animal (Shepherd et al. 1994, Braun et al. 2011, Heredia et al. 
2013). In light of these prior studies, we sought to determine if the behaviors were associated with 
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calcium transients. By examining the synchronized TCSPC peaks we found that the calcium peaks were 
associated with specific behavior patterns (Figure 22). We found that calcium peaks were correlated with 
one of the following behaviors: initiation of forwards movement, initiation of backwards movement, 
initiating rearing, initiating sitting, nose poking, right turns, left turns, walking backwards, grooming, 
moving between the middle zone to the open or closed arms. With the exception of grooming, we did not 
observe any of these behaviors to occur without creating calcium transients. Interestingly, grooming, 
which is classically considered to be associated with striatal circuitry (Lovinger 2017), was only rarely 
associated with calcium transients.  
 Finally, we sought to determine if these calcium transient associated behaviors were differentially 
expressed in the different zones of the maze. By examining behaviors that have been shown to be related 
to anxiety state, we found that both total behaviors (Figure 23 top), and behaviors adjusted for time spent 
in each arm (Figure 23 bottom), were significantly increased in the closed arms of the maze compared to 


















 derivative of ΔF/F was used to detect significant rise in fluorescence 
GFP control – no significant rise according 1
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 derivative of ΔF/F 
5% FDR 
criterion 
Figure 19. Tim’s algorithm to detect Ca2+ peaks: Significantly high 1st derivative of ΔF/F detects 
rise of Ca2+ transient [4-5]. Multiple comparison corrected using False Discovery Rate (FDR) at 5%. 
Return to baseline defined as ΔF/F decaying to baseline’s mean + 0.5 S.D [6]. Peak identified as 






Figure 20. Time spent in each zone of the elevated plus maze. Top: the time spent in the 
closed arms of the maze for all groups combined was significantly greater than time spent in 
the middle zone and open arms of the maze. Bottom: considering the groups separately 
both Dd1 (direct path) and D2 (indirect path) mice spent significantly more time in the closed 






Figure 21. Rate of calcium peaks per minute in the different zones of the elevated plus maze. 
Top: calcium peaks per minute for both paths combined was significantly greater in the closed arms 
of the maze than the open and middle arms. Bottom: The rate of calcium peaks per minute were 
significantly greater in the closed arms of the maze than in the middle or open arms.  
85 
 
Figure 22. Annotation of different calcium peaks. This illustrates the method of evaluating each 





Figure 23. Behaviors displayed by mice in the elevated plus maze. 
Top the total average numbers of eight different behaviors displayed in 
the open arms compared to the closed arms averaged across all mice. 





This study is to our knowledge the first in vivo recording from the direct and indirect paths in the dorsal 
striatum in the mouse during a behavioral task of anxiety. Similar to previous publications (Walf and Frye 
2013), we find that the mice prefer to spend time in the closed arms of the maze and that they exhibit 
more behaviors in those arms (Figure 23). We also find that both the direct and indirect paths exhibit 
increased activity while the mouse is in the closed arms (Figure 21). This increased firing is correlated 
with the higher levels of behaviors in the closed arms of the maze (Figure 22).   
A possible conclusion is that the direct and indirect paths exhibit higher activity when the mouse is 
experiencing a lower anxiety state. As motor behaviors have been correlated with the anxiety state of the 
animal (Shepherd et al. 1994, Braun et al. 2011, Heredia et al. 2013), we surmise that the larger level 
motor behaviors in the closed arms correlates with the lower anxiety state. We believe this is the first in 
vivo confirmation for a potential role of the direct and indirect paths of differential modulation of motor 
patterns in different anxiety states. We are not able to determine from these results whether the DLS 
plays a role in the perception of anxiety in addition to the motor behavior associated with the anxious 
state.  
An important limitation of the elevated plus maze is that open arm exploration can have several 
confounding variables. Increased entries into the open arms could, in addition to reduced anxiety, be due 
to increased novelty seeking or reduced impulse control.  Therefore, additional tests of anxiety, such as 
active avoidance or novelty suppressed feeding, to further analyze the association with DLS activity and 





We plan to repeat these experiments with a new cohort of mice that have been pretreated with 
benzodiazepines. Since benzodiazepines have been shown to be anxiolytic and increase the time spent 
in the open arms, we hypothesize that they will increase the exhibition of motor patterns in the open arms 
and that we will record a corresponding increase in the direct and indirect path firing rates. We are also in 
the process of determining whether the waveform of the calcium transient differs depending on the 
behavioral pattern. We further intend to examine the role of cannabinoid and DA modulation. Some 
studies have implicated DA signaling through the D3 receptor and cannabinoid signaling on CB1 
receptors in the mesolimbic circuit to the ventral striatum and mPFC in the pathogenesis of anxiety 
(Leggio 2014, Wei 2017). Finally, in these mice we studied dSPNs and iSPNs in the DMS that comprise 
the associative path and we intend to follow up these results with recordings from the sensorimotor path 
via fibers implanted in the DLS and examine if the results are similar in the sensorimotor path.  
We plan on analyzing the videos to determine if there is an association between the size and frequency of 
calcium transients and the type of behavior that the mouse is demonstrating. To do this, we will analyze 
the videos by hand and match different behaviors to different peaks. We will use logistical regression 








CHAPTER 7: GENERAL DISCUSSION AND FUTURE DIRECTIONS 
This chapter offers a general discussion on the research in the previous chapters and considers the 
future experimental directions.  
In my first set of experiments, we utilized in-vivo multiphoton imaging of a NE specific fluorescent false 
neurotransmitter (FFN) AGH270 in mice surgically implanted with a cranial window to visualize 
noradrenergic release from each individual synapse. We either infused or microinjected FFN270 into 
barrel cortex of wt B6 mice, an area critical for processing sensory perception. We chose the barrel cortex 
as a model as the sensory cortex has been shown to be abnormal in children with ADHD (Francx et al., 
2016), and because cortical noradrenergic synapses comprise an important therapeutic target of the 
ADHD treatments AMPH, methylphenidate, and atomoxetine. AMPH’s action in the cortex in vivo had 
previously only been indirectly observed via SPECT or PET imaging and microdialysis.  
We hypothesized that AMPH would cause vesicular release of NE and that the magnitude of its effect 
may differ between synapses. We found that in the absence of sensory stimuli, only a small subset of 
noradrenergic synapses actively released FFN, consistent with the phasic activity of the locus coeruleus. 
However, at 1mg/kg d-AMPH (i.p.), a mouse dosage equivalent to that used for treatment of ADHD, the 
FFN was emptied from all synapses within 10 minutes. This provides the first in vivo confirmation that 
AMPH can cause release of vesicular NE at treatment relevant doses. The effect was more rapid with 10 
mg/kg, dosages associated with AMPH abuse. Surprisingly, AMPH’s ability to cause complete release 
from all synapses was uniform and occurred in the absence of sensory stimulus to the cortex. This data 
supports the network reset theory of noradrenergic cortical function and is consistent with an action by 
which NE filters cortical neurons to tune out less salient stimuli. 
We believe that our optical data provides convincing proof that AMPH causes complete NE release at the 
pharmacologically relevant dosage of 1mg/kg, as we are able to optically observe exocytosis,. We can 
also quantify the amount of release, in contrast to previous papers that were unable to determine the 
extent compared to reuptake at the lower dose range because they use slower bulk methods of 
measurement such as microdialysis.  We believe this is both the first time that neurotransmission from 
individual presynaptic sites as well as its modulation by AMPH has been observed in mammalian brain in 
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vivo. This technique far exceeds the spatial and temporal resolution of either SPECT or PET imaging, and 
by providing a means to study of individual synapses, elucidates the synaptic mechanisms of 
noradrenergic drugs 
Another interesting finding resulting from the experiments with FFN270 is the evidence for heterogenous 
release of neurotransmitters. We found that a small portion of release sites would not fully release the 
FFN, even after optogenetic stimulation. These findings seem to support a recent study that found 
evidence of silent synapses by using FFN200 in the striatum (Pereira et al. 2016). The FFN200 study 
used electrical stimulation of dopaminergic axons and found that most axons that display GCaMP3 
transient would not release the FFN. However, little is known about the mechanism of plasma membrane 
accumulation or selectivity of FFN200. Follow-up experiments with other FFNs in different brain regions 
are necessary to confirm these findings and to determine whether they are indicative of the underlying 
biological mechanism of synaptic release, or an artifact of the FFN.   
Limitations of FFNs 
There are several limitations of FFNs. First, they cannot be used to distinguish between release of 
neurotransmitter that occurs during vesicular fusion, and release that occurs during other methods of 
neurotransmission such as the kiss-and-run form of neurotransmitter release. In this case, release from a 
vesicle occurs through brief opening of a fusion pore rather than full fusion (Ceccarelli et al. 1973, Henkel 
and Betz, 1995). One potential interpretation of a bouton does not rapidly destain is that it has switched 
its mode to of release from vesicular fusion to kiss-and-run. This switch in mode of transmission has been 
proposed occur during mGluR-dependent LTD (Stanislav et al., 2002).  
Another limitation is in the interpretation of puncta that do not destain with stimulation. FFN imaging alone 
cannot be used to determine whether these puncta may have been damaged by the surgery and are thus 
not functioning normally. Using FFN270 in neurons that co-express GCaMP6f would help to resolve this 
issue, as the presence of a calcium transient can help determine if the neuron is undergoing calcium 
influx. If there is no calcium transient, then the puncta is likely not depolarizing and puncta that do not 
destain may be damaged or may not have been stimulated.  Additionally, FFN270 may be accumulated 
into reserve pools of puncta that may not release with initial levels of stimulation. While we did not find 
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this to be the case with AMPH induced release, this may be an issue with other methods, such as 
channelrhodopsin or electrically simulated release.  
Future directions 
An interesting future direction would be to study AMPH release in different mouse models of disease. 
This would provide important translational information about the effects of the genes linked to the mouse 
disease models and could provide a link between gene function and alterations in cortical NE. 
Furthermore, the ability to simultaneously image FFN270 and GCaMP6f will provide information on the 
basis of such deficits in different mose models with different genetic defects. The FFNs will provide 
determination of any changes in the kinetics of release. An increase in the t1/2 of the release signal may 
implicate a defect in vesicular release of NE. If fewer synapses are observed with FFN270, there may be 
a problem with vesicular loading, perhaps involving NET. Fewer puncta overall may suggest that the NE 
projections are sparser in the disease model than in wild type mice. If there is a lower rate of calcium 
transients observed via GCaMP6f, one may conclude that there is a lower rate of firing. Another 
possibility is that there will not be any differences in either anatomy or firing rate of NE neurons, or 
kinetics of NE release. One may then conclude that any mechanisms involved in a NE deficit may include 
other factors, such as rapid breakdown of NE by catechol-o-methyl transferase (COMT).  
A second future direction for FFN270 includes determining whether the probability or degree of release 
changes when mice undergo a task of learning. In this case, the speed and degree of destaining of 
puncta filled with FFN270 could be studied over several days. After a pre-training baseline has been 
established, the mice could be trained on a task involving learning. Changes in puncta destaining could 
be compared to the baseline.  
Additional experiments may seek to explore deficits in working memory (WM).   WM depends on optimal 
catecholamine levels in the mPFC (Seemans et al. 1998). Mouse models of psychiatric disease exhibit 
deficits in WM, deficits in cortico-subcortical circuits (Ellegood et al. 2014), and cortical catecholamine 
deficits (Murotani et al. 2007). Simultaneous multiphoton imaging of FFN release from cortical projections 
and the firing rate of those projections via GCaMP6f in the medial prefrontal cortex (mPFC) of mouse 
models of disease as they perform a delayed nonmatch to sample (DNMS) task of WM (Liu et al. 2014) 
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could provide important information on catecholamine deficits that occur during active cognitive 
processing in these models.  
Imaging the natural transmission of NE in the absence of a NE releasing drug such as AMPH would have 
translational relevance and may unmask deficits that are not apparent with drug interventions. This would 
allow the determination of the kinetics of NE release in wild type and psychiatric disease model mice 
during a physiologically relevant task. If the mice have impaired performance on a task of WM and exhibit 
aberrant cortical catecholamine transmission during this task, this paradigm should provide some insight 
into the nature of such catecholamine deficiencies.    
I expect that with this paradigm the researcher will be able to compare differences in catecholamine 
kinetics, number of active terminals, and the firing rate of the catecholamine projections between wild 
type and disease model mice during the DNMS task of WM. It is possible that both the mechanism and 
degree of catecholamine deficit may differ between the different mouse models of psychiatric disease. 
It has been shown that during the learning of a new classical conditioning task, increased activity in VTA 
mesocortical neurons and catecholamine release in the mPFC initially correlates with the time of the 
reward (unconditioned stimulus) to the time of the cue (conditioned stimulus). It is possible that in wild 
type mice, FFN release will initially correlate with delivery of the reward, and as the mice learn the task, 
FFN release will shift to presentation of the second cue. In mouse models of psychiatric disease, 
however, this shift may not occur within the same time frame of the wild type mice. A second possibility is 
that these neurons will show deficits in NE release, the nature of which will be able to be determined with 
FFNs and GCaMP6f. An increased t1/2 of detaining may indicate deficits in vesicular release and lower 
rates of GCaMP6f transients may indicate lower firing rates of catecholaminergic neurons.  
Another possibility is that the degree of impairment on the task of WM correlates with the degree of 
catecholamine deficit. The use of FFNs will allow the determination of a correlation between a 
catecholamine deficit and a WM deficit. Note, however, that WM depends on neuromodulators other than 
DA and NE levels in the mPFC, such as acetylcholine via muscarinic receptors in the mPFC. If the degree 
of deficit in WM does not correlate with deficits in catecholamine transmission, one may conclude that the 
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impairment on the task was due to other factors, such as the involvement of additional neuromodulatory 
systems or other circuit deficits that will not be tested in these experiments.  
 
PHASOR 
In my second set of experiments, I introduced a new method of cranial window surgery: PHASOR. This is 
an improvement in cranial window surgery that I initially developed to improve the use of FFNs in vivo. 
Cranial window surgery to prepare rodents for multiphoton imaging in vivo has become widespread in 
neuroscience. This surgery can be categorized into two main groups: surgeries in which a circle of bone 
is completely removed, and surgeries in which a circle of bone is thinned but not removed from the skull, 
i.e., “thin skull technique.”  The removal or thinning of bone is necessary to prepare the mouse for optical 
imaging with a multiphoton microscope. Both of these surgeries make use of a high speed rotary drill to 
either thin or remove the bone from the skull. Because rotary drills will cut through both bone and soft 
tissue there is a high risk of damaging the dura and underlying blood vessels. The success of the surgery 
depends on the skill and hand eye coordination of the surgeon. Piezosugery was originally developed by 
Tomaso Vercellotti (Vercellotti et al. 2000) and has led to improvements in dental and cranio-maxilofacial, 
facial plastic surgery, ocular plastic surgery, and pediatric surgery in humans. We believe our data is the 
first application of piezosurgery to prepare mice for multiphoton imaging. Piezosurgery can be used to 
create both thin skull and complete bone removal windows. The use of a piezoelectric cutting device 
resulted in faster surgeries that were easier for new surgeons to perform, and had fewer complications 
that that from a high speed rotary drill. The advantages of speed and ease of use may be dependent on 
the surgeon because it is possible that given highly trained surgeons they will be able to create cranial 
windows with a dental drill with equal speed: however not everyone has the required excellent hand eye 
coordination and the results for new surgeons is apparent. We hope that the application of piezosurgery 
to mice will result in safer surgeries for mice and better surgical outcomes. In future experiments we hope 
to determine the effects of piezosurgery on neuronal inflammation. We will follow up with immunostains 
for neuronal markers of inflammation and microglia activation and compare these to traditional cranial 
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windows. We hypothesize that piezosurgery will result in lower levels of inflammatory markers, however 
this is an important control to perform.  
TCSPC 
In a separate set of experiments, we sought to analyze the firing rates of the dSPNs and iSPNs, of the 
direct and indirect paths respectively, during the elevated plus maze, a rodent task of anxiety. We found 
that the direct and indirect path SPNs exhibit higher rates of firing when the mouse was in a lower anxiety 
state. We also noted that in the closed arms of the maze, the mice exhibited higher levels of behaviors 
that are associated with a lower anxiety state. These behaviors were correlated with specific calcium 
transients. These results are important because the striatum is not typically a structure analyzed in the 
much studied anxiety loop, which includes the hippocampus, prefrontal cortex, and amygdala. There is 
nevertheless evidence from human MRI studies that the dorsal striatum plays a role in the processing of 
anxiety. Those studies found that increased intolerance of uncertainty correlate with increased striatal 
volume, and that patients with OCD possess increased striatal gray matter while patients with PTSD and 
panic disorder showed reduced in gray matter. Importantly, striatal volume correlated with markers of 
anxiety even in individuals who did not meet the criteria for an anxiety disorder suggesting that the 
striatum may play a role in the processing of anxiety (Hilbert 2015, Radua 2010, Kim 2017). Also relevant 
is evidence that deep brain stimulation of the striatum is an effective treatment for treatment refractory 
OCD (Denys et al. 2010, Gabriels et al. 2003, Greenberg et al. 2010). Our results, implicating a potential 
role of the striatum in anxiety are congruent with these studies. However, until pharmacological 
manipulation and more extensive anxiety tests are conducted, we are unable to determine the precise 
role of the striatum in anxiety. In follow-p experiments, we plan to repeat our recordings from the dSPN 
and iSPNs during other tasks of anxiety including the open field, the zero maze, and novelty suppressed 
feeding (Njung’e et al. 1991, Nicolas et al. 2006, Treit et al. 1981, Dulawa et al. 2004).  
Another potential interpretation of these results are is that the striatum plays a role only in the motor 
output of anxiety, and not the perception or emotional state related to anxiety. In order to better 
understand its precise role, we also hope to test if drugs that are prescribed to humans to reduce anxiety, 
such as benzodiazepines and SSRIs, will have an effect on either the dSPN and iSPN firing rates, or the 
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behaviors the mouse exhibits in the maze. We recorded from the DMS because it receives input from the 
mPFC, which is implicated in the classic anxiety loop. Future experiments could include optogenetic 
silencing or stimulation of brain regions more typically implicated in anxiety, such as the amygdala, with 
simultaneous TCSPC recording from the striatum. It would be important to know if stimulation or inhibition 
of different parts of the classic anxiety loop would change the firing rate of the dSPNs and iSPNs in the 
dorsal striatum. If such changes could be observed, it would suggest that the classic loop features inputs 
into the striatum relevant to anxiety processing. Finally, it would be important to record from the DL, which 
receives input from motor and somatorsenory cortex, to determine if there are changes in this area as 
well.  
Finally, in a preliminary set of experiments included as an appendix, we used viral vectors to express 
GCaMP6f in the dSPNs and iSPNs of the direct and indirect paths. By implanting optical fibers in the 
DMS and DLS, we were able to use TCSPC to record from the associative path and sensorimotor paths 
respectively. A portion of the mice had bilateral fibers implanted in both the left and right DLS. First, we 
examined the synchrony of peaks in the left and right striatum during goal directed tasks and found 
correlation of synchronous and asynchronous peaks during specific behaviors. We believe this is the first 
time that synchronous peaks between the left and right striatum have been observed. These results are 
intriguing and bring up unanswered questions. First, does the synchrony between peaks in the left and 
right striatum involve bridging collateral communication between hemispheres? Alternatively, are these 
seemingly synchronous but temporally phase shifted peaks produced independently? We would expect 
that a 6-hydroxydopamine hemi-lesion model of Parkinson’s disease change the synchrony on one side, 
although this may also have effects on the nonlesioned side.  
As this approach can record realtime changes in the dSPNs or iSPNs on both hemispheres, it would 
provide an optimal system to study levodopa induced dyskinesia. With this system, the effects of potential 
treatments such as cholinergic modulation on the firing rates of the direct and indirect paths could be 
visualized in real time.  
In the next chapter of our motor skill learning experiments, we sought to measure the firing rate of the 
dSPNs and iSPNs changed during motor skill learning and determine if there was a difference in the 
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change of rate in the SPNs located in the DMS compared to the DLS. Unfortunately, multiple technical 
problems plagued this set of experiments and severely limited our present conclusions. We did, however, 
find that in the treadmill task of motor skill learning, dSPNs and iSPNs in the DLS show a significant 
decrease in firing. During the rotarod, parallel bars, and high bar, iSPNs indicate trends toward decreased 
firing, dSPNs in the DMS displayed a significant increase in firing between days 1 and 2 of motor skill 
learning. We also were able to verify that both the DMS and DLS are active during the days of motor 
learning.  
While not yet complete, we think that these are important studies as the role of the DMS associative path 
and the DLS sensorimotor path during motor learning has been the subject of much controversy. The 
most recent and technically advanced study, Kupferschmidt et al. (2017), found that corticostriatal 
projections to the DMS shows low activation on the first day of learning that rapidly increases by the 
second day and then reduces again by the third day. In contrast, the corticostriatal projections to the DLS 
exhibited highest levels of activity on day one, and these levels decreased during each subsequent day of 
training. Our results are relevant, as by recording from the dSPNS and iSPNs of the direct and indirect 
pathways, we are measuring the next step in the cortico-striato-thalamo-cortico loop. Our results suggest 
that the changes in firing during motor learning are similar to those observed by Kupferschmidt et al. 
2017, and the reduction in firing could be due to refinement of neuronal firing as would be expected by 
the results of Jin et al. 2014, and Klaus et al. 2017. Overall, this reduction would be in support of the 
neuronal ensemble hypothesis, that neuronal circuits become increasingly refined as learning occurs 
(Fingelkurts et al. 2004). Our results need to be followed with larger numbers of mice in order to reach 
significance. Follow-up experiments should also record from the mice for the entire 5 day period of motor 
learning. If our results are indeed significant, and the changes we observed are consistent over the full 
time period, the next step would be to determine if these changes in firing are due to changes in plasticity 
occurring on the synaptic level. Since a combination of DA, endocannabinoids, metabotropic glutamate, 
and cholinergic interneurons have been implicated in modulating corticostriatal plasticity (Wong et al. 
2015, Bamford et al. 2009), we would seek to determine their role on the changes in dSPN and iSPN 
firing rates during motor skill learning. It is our hypothesis that cannabinoid receptor 1 antagonists such as 
AM-251, which interfere with the changes in corticostriatal plasticity, would also inhibit the mouse’s ability 
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to learn the motor task. To further examine the role of DA on these tasks, they could be repeated with D1 
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THE STRIATUM IN MOTOR SKILL LEARNING 
Presented here are the early results of some preliminary studies examining the changes that occur in the 
direct and indirect paths during behavioral tasks involving motor learning.  
ABSTRACT: 
The ability to learn new and more complex motor skills increases the ability to find food, escape from 
predators, and the chance of survival. Motor skill learning comprises an acquisition period, where a motor 
skill is goal directed, and a mastery period where a motor skill has become automatic (Corbit 2017). 
Striatal spiny projection neurons (SPNs) regulate movement through two major circuits. The direct 
pathway SPNs project to the substantia nigra pars reticulata (SNr) and globus pallidus interna (GPi). The 
indirect pathway SPNs expressing D2 receptors (iSPNs) trigger a multisynaptic circuit, synapsing to the 
globus pallidus externa (GPe), which then projects to the SNr. These paths can be further subdivided by 
anatomical location and cortical input. The dorsomedial striatum (DMS) comprises the associative path, 
and the dorsolateral striatum (DLS) comprises the sensorimotor path. Both the DMS and DLS have been 
implicated in motor skill learning. To our knowledge, there are no studies examining the extent of 
synchronous activity between left and right striatum in either the direct or indirect paths in the DMS or 
DLS during locomotion or motor skill learning.  
We used time correlated single photon counting (TCSPC) to record neuronal activity in the direct and 
indirect paths in both the left and right DMS and DLS. D1-Cre (direct path) and A2A-Cre (indirect path) 
mice were injected with AAV9 Flex GCaMP6f virus. Imaging fibers were implanted in both the right and 
left dorsal lateral striatum. We adapted a camera to record mouse movement. Mice were recorded with 
the high speed video camera framelocked to the sampling rate of the TCSPC machine. This enabled us 
to perform simultaneous recording from both the left and right DMS and DLS with millisecond precision, 
allowing us to correlate locomotor behavior with GCaMP6f changes in fluorescence.  
We found evidence of synchronous and asynchronous activity as determined by both amplitude and 
frequency of firing in DLS during goal oriented behaviors in mice. We also found a significant decrease in 
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calcium transients in the direct and indirect path neurons during motor learning. This is to our knowledge 
the first in vivo optical recording data suggesting that there is a reduction in direct and indirect path 
neuronal activation during motor learning and supports a “neuronal ensemble” hypothesis (Klaus et al. 
2017).  
Introduction.  
The ability to learn new and more complex motor skills increases the ability to find food, and escape from 
predators and increases the chance of survival. In addition to its role in executing already learned motor 
skills through motor pattern support and suppression, the striatum is thought to play an important role in 
the learning of new motor skills. In disorders of the striatum such as Parkinson’s and Huntington’s 
disease, the ability to learn new motor skills is compromised (Nambu 2008). While many brain regions, 
notably including the cerebellum, are implicated in motor learning (Dempsey and Sawtell 2016), this study 
focuses on the potential role the direct and indirect paths of the striatum in motor skill learning.  
Motor skill learning has been described in two periods, as an acquisition period, where a motor skill is 
goal directed, and the mastery period, where a motor skill no longer requires conscious control and the 
actions becomes automatic (Corbit et al. 2017). The motor acquisition period can be conceptualized as 
learning to ride a bicycle. During this period, which may take many days, the subject must be cognizant of 
feedback from failed attempts and readjust their technique accordingly. However, once mastery is 
achieved, riding the bicycle becomes automatic. This skill is also long lasting, persisting even in the 
absence of further practice.  
Striatal spiny projection neurons (SPNs) regulate movement through two major circuits. The direct 
pathway SPNs project to the substantia nigra pars reticulata (SNr) and globus pallidus interna (GPi). The 
indirect pathway SPNs expressing D2 receptors (iSPNs) trigger a multisynaptic circuit, synapsing to the 
globus pallidus externa (GPe), which then projects to the SNr. Activation of the direct and indirect paths 
correlates with enhanced locomotion in mice. These two paths can be further subdivided depending on 
cortical input and spatial location.  The associative path comprises cortical input from the medial 
prefrontal cortex (mPFC) to the dorsal medial striatum. The sensorimotor path comprises cortical input 
from primary motor and somatosensory cortex to the dorsolateral striatum. In an older model, the 
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associative path was theorized to play an important role in motor skill acquisition, while the sensorimotor 
path controls execution of already mastered motor skills (Graybiel et al. 2008, Corbit et al. 2017). Prior 
research disrupting each path has found that disruptions in the associative path result in loss of the ability 
to acquire new motor skills, but do not impair already learned motor skills while disrupting the 
sensorimotor path results in disruptions of previously learned motor skills. In this case, previously 
mastered skills return to conscious control. (Yin et al. 2009, Redgrave et al. 2010). A refinement on this 
model suggested that the DLS and DMS compete for control during motor learning (Thorn et al. 2010). 
This model was theorized without the techniques to record from only the corticostriatal neurons involved 
in each path, but such techniques have now been developed. In a recent study, Kupferschmidt et al. 
(2017) used time correlated single photon counting to record presynaptic calcium transients from either 
the associative path or the sensorimotor path in mice during training on the rotarod, a rodent task of 
motor skill learning. In support of the revised model, they found that both paths were simultaneously 
active during skill acquisition and execution of mastered skills. However, in contrast to the previous 
models, they found that both paths were most active during the skill acquisition and less active during 
execution of mastered skills. They were able to further subdivide the skill acquisition period into two 
categories: 1) The naïve period, is the first day the animal is introduced to the motor skill. 2) The early 
period which is the second day the animal practices the motor skill. The late period describes the period 
of automatic execution of already mastered skills (Kupferschmidt et al. 2017.  
If we were to conceptualize these timepoints with the example of learning to ride a bike, the naive period 
would be the first day the person attempts to ride the bicycle, the early period would be the second day 
the person practices riding, and the late period would be when bicycle riding mastery has been achieved.  
Interestingly, Kupferschmidt (2017) found that the associative path shows low activity during the naïve 
period, increases to its highest activity during the early period, and then drops to low activity during the 
late period. The sensorimotor path shows its highest activity immediately during the naïve period, and 
slowly decreases during the early period to the lowest activity in the late period.  
To address whether these changes in path activation were due to presynaptic modulation of corticostriatal 
terminals, Kupferschmidt compared firing rates of the soma in mPFC and M1 to the firing rates of the 
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presynaptic terminals of the associative and sensorimotor paths. They found that the firing rate changes 
in the cortical soma lagged behind the changes observed in the presynaptic terminals, indicating that 
presynaptic changes occurred first.  
While Kupferschmidt’s findings are able to dissociate the associative and sensorimotor paths during 
motor learning, they do not address whether the direct and indirect paths in the DMS and DLS exhibit 
similar changes in firing.  In order to answer this question, used time correlated single photon counting 
with a machine similar to that used by Kupferschmidt and colleagues. We transfected mice expressing cre 
recombinase in A2A-receptor-expressing neurons and D1-receptor expressing neurons with AAV9 Flex 
GCaMP6f virus into either the DMS or DLS, and implanted bilateral imaging fibers in the same site 
(Figure 24). Mice were recorded with a high speed video camera framelocked to the sampling rate of the 
time correlated single photon counting machine. This enabled us to acquire simultaneous recordings from 
the left and right DMS or DLS at millisecond precision, providing a means to correlate locomotor behavior 
with GCaMP6f changes in fluorescence. In mice implanted with bilateral fibers, we were also able to 
examine striatal synchrony during a variety of behavioral tasks.  
MATERIALS AND METHODS 
Experiment 1. Double fiber freely moving behavior in DLS 
Mice 
Adult 8 week old male D1-Cre (GENSAT FK-150) and A2A-Cre (MMRRC 036158) mice were housed in a 
reverse light cycle room. All behavioral experiments were performed in the dark cycle of the mouse. All 
procedures were conducted in accordance with Institutional Animal Care and Use Committee (IACUC) of 
the New York State Psychiatric Institute.  
Viral injection and fiber Implant Surgery 
Mice were injected with buprenorphine (0.05- 0.1 mg/kg) prior to anesthesia and anesthetized with 
isofluorane (1-4%). Marcaine diluted 50% in saline was injected under the scalp to provide local 
anesthetic. The body temperature of the mouse was maintained for the duration of imaging with a heating 
pad. The depth of anesthesia was monitored by both the animal’s response to toe-pinch every 5 min and 
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observation of respiratory rate.  Once the proper depth of anesthesia was reached, the animal was placed 
in a small animal stereotactic apparatus on top of a heating pad and Puralube vet ointment was applied to 
the eyes to prevent vision loss. All surgical procedures were performed in a sterile manner. Marcaine 
(0.5%) with saline 1:2 (0.25%) (2 mg/kg), was injected subcutaneously along the midline of the scalp as a 
local anesthetic. Before the incision, the hair over the scalp area was removed with NAIR and sterilized 
with a gentle scrub with Betadine on a sterile cotton swab, followed by 70% ethanol, repeated 3 times. 
The scalp was then removed with surgical scissors, membranes over the skull were removed by scraping, 
and the exposed bone was dried with compressed air. A 1 mm hole was then made over the dorsal 
striatum with a high speed dental drill (Midwest Stylus 360). Any bleeding from the bone or dura was 
stopped with an application of collagen foam (Avitene Ultrafoam, Bard Davol). A glass pipette attached to 
a Nanoject II (Drummond Scientific) was filled with AAV9 Flex GCaMP6f virus (UPENN Viral Core) (300 nl 
of 1013 viral units/ml), and attached to the stereotax. A volume of 300ul of virus was injected into the 
dorsal striatum (1 mm AP, 1.0 mm ML, over several depths (DV: 3.0mm, 2.5 mm, 2,2mm) with 3 minutes 
of delay per depth. The glass pipette was then withdrawn from the brain and an imaging fiber was then 
implanted into the dorsal striatum at the location of the injection (1 mm AP, 1.0 mm ML, 2.5mm DV (DLS) 
and 1 mm AP, 1.0 mm ML, 1.0mm DV (DMS)). The fiber was then secured to the skull with dental acrylic 
(Parkel Metabond). The mouse was then transferred to a heated cage to recover.  
Time correlated single photon counting 
To measure neural firing patterns in the two striatal pathways, mice were tethered the TCSPC machine 
(custom built from Becker Hickl parts). GCaMP6f was excited with a 473 nm picosecond pulsed laser 
(Becker Hickl). Mice were tested while freely moving and awake on the selected behavior task while 
GCaMP fluorescence was measured by the TCSPC in a population of neurons within 300 μm of the 
implant. Photon counts were recorded by TCSPC Image software from Becker Hickl. 
Data analysis 
High speed videos were analyzed and behaviors were scored by hand and annotated onto the recordings 
from the TCSPC machine. The following behaviors were observed to be correlated to calcium transient 
peaks: initiation of forwards movement, initiation of backwards movement, initiating rearing, initiating 
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sitting, nose poking, right turns, left turns, walking backwards, grooming, digging, body shaking, 
responding to air puff, swimming. Calcium transients were evaluated with a custom Matlab script.  
Behavioral Tasks 
Before all tasks mice were brought to the behavior room 1 hour before testing.  
The home cage 
Mice housed in a standard 75sq/in plastic cage with bedding were tethered to the TCSPC machine and 
the camera was set to record through the clear side of the cage. The light in the behavior room was set to 
red light only. Mice were allowed to move freely in their home cage for 10 minutes while being recorded.  
The cylinder 
Mice were placed in a 6inch diameter clear Plexiglas cylinder. The floor was covered in clean bedding 
prior to experiments. The mice were tethered to the TCSPC machine and the camera was set to record 
through the clear side of the cylinder. The light in the behavior room was set to red light only. Mice were 
allowed to move freely in the cylinder for 10 minutes while being recorded. The cylinder was washed and 
bedding was changed between mice.  
The treadmill 
The treadmill apparatus is a 1 m long 10 cm wide moving treadmill. The back legs of the mice are held in 
the hand and the mice are balanced so that only their front paws are on the treadmill (Figure 25). The 
mice are trained to walk forwards for a period of 8 days followed by a break from days 8 to 13 without 
training. On the thirteenth day, forward walking training continues, and reverse walking training starts. 
During each day of testing the mice perform 10 trials of walking forwards for 10 seconds followed by 10 
seconds of rest. During reverse training the mice perform 5 trials of forward walking followed by 5 trials of 
reverse walking.  During the behavior tasks the mice are tethered to the TCSPC machine and a camera is 





This behavior was performed as described in Deacon 2013. On the rotarod, the mice walk on the 
horizontal rotating axis as the rotations per minute increases. The rotarod was set with a start speed of 
4rpm and a rate of acceleration of 20 rpm. The acceleration started 10 seconds after placing the mouse 
on the rotarod. The mouse was held by the tail and placed on the rotarod facing away from the direction 
of rotation. This enables the mouse to walk forwards to stay on the bar. Mice are tested on both the 
treadmill and rotarod (until they fall or stop walking and hold onto the bar for a complete rotation) for five 
consecutive days while tethered to the TCSPC machine. While running through these behavioral tasks, 
mice were recorded on slow motion video, synced with TCSPC, to allow correlations between the firing 
patterns and behavior to be studied. The light in the behavior room was set to red light only. 
The parallel-bars 
The parallel bars were constructed and behavior was performed as described in Deacon 2013. Two 
parallel plastic bars of 1m length and 4mm diameter were fixed 30mm apart to posts at each end and 
elevated 60cm above the floor. Mice were tethered to the TCSPC machine and an overhead camera was 
set to record. The light in the behavior room was set to red light only. Each mouse was placed in the 
center of the parallel bars. The experiment was concluded when the mouse would move to the end of the 
bars and climb onto a post.   
The high-bar 
The high-bar was constructed and behavior was performed as described in Deacon 2013. A plastic bar of 
1m length and 3mm diameter was fixed between two posts and elevated 60cm above the floor. Mice were 
tethered to the TCSPC machine and an overhead camera was set to record. The light in the behavior 
room was set to red light only. Each mouse was placed in the center of the high-bar. The experiment was 
concluded when the mouse would move to the end of the bar and climb onto a post.   
RESULTS 
Experiment 1. Double fiber recordings of synchronous and asynchronous firing.  
We found evidence of synchronous and asynchronous activation of the dSPNs and iSPNs in the DLS 
during several behaviors. We tested the mice on 4 different behavioral paradigms: the corridor test, home 
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cage, the cylinder, and swim tests. We found that synchrony of peaks during behaviors in the behavioral 
paradigms could be classified into four broad categories. Unilateral right peaks, unilateral left sided 
peaks, synchronous right and left peaks, and asynchronous left and right peaks (Figure 26). While we did 
not find behaviors that were purely associated with one specific type of peak, we found associations 
between the behaviors and types of peaks.  
Unilateral right and left peaks were most associated with turns in the either the contralateral direction or 
the ipsilateral direction. Shaking of the body was most associated with bilateral synchronous peaks. 
Asynchronous peaks were most associated with the periods of rearing and  
Experiment 2. Recording from dSPNs and iSPNs in DLS during the treadmill task of motor skill 
learning.  
Our results show that SPN in the DLS show high levels of activation during motor learning on the 
treadmill. We found that this activation tapers off as the mice practice treadmill walking (Figure 27). Mice 
showed a significant decrease in firing rate when performing the forward walk from day 6 to day 7 in both 
pathways. After training for a 7 days of reverse walking training, the mice became proficient at reverse 
walking, and a significant decrease in firing rate was observed (two-way ANOVA P<.05). Interestingly, 
while both the direct and indirect path show similar levels of reduction in firing, the indirect path starts at a 
lower baseline. In the indirect pathway at the start of reverse walking, the neurons did not fire as 
frequently as they did in the direct pathway (Figure 27). The low firing rate suggests that perhaps 
learning to walk forwards also helped the mice with learning to walk backwards. 
Experiment 3. Recording from iSPNs in the DLS and dSPNs in the DMS during the rotarod task of 
motor skill learning.  
We found that on the first day of training, activation of dSPNs and iSPNs in the DMS was relatively low. 
The level of activation in the direct and indirect path was significantly higher on day two than on day 1 
(P<0.05, two tailed t test) (Figure 28). In the DLS, rotarod activity was highest on day 1 and showed a 
trend to decrease on the second day of training. However, our results did not reach significance (Figure 
28). Technical difficulties prevented us from recording from the dSPNs in the DLS and iSPNs in the DMS.  
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Experiment 4. Recording from iSPNs in the DLS during the parallel and high-bar bar tasks of 
motor learning.  
Similar to our findings in the rotarod, in the DLS, we found dSPN and iSPN activity was at a maximum on 
the first day and reduced by the second day of training. However this trend did not reach significance 
(Figure 29).  
Experiment 5. Recording from iSPNs in the DLS during the high-bar bar task of motor learning.  
In the DLS, we found dSPN and iSPN activity was at a maximum on the first day and reduced by the 




Figure 24. Diagram of experimental technique. 1) AAV90.FLEX.GCaMP6f virus is injected into the 
striatum. 2)A fiber optic is implanted into the same area during the same surgery. 3) The mouse is 
tethered to the TCSPC machine. 4) Blue laser light is pulsed into the brain with picosecond frequency. 
5) GCaMP6f is excited by the laser and attains a high  green fluorescence confirmation when it binds 
calcium in active neurons. 6) Green fluorescence emitted by GCaMP6f travels through the fiber and is 





Figure 25. Mouse on the treadmill. The mouse is 
held in the hand with the back legs supported by the 
investigator. The front paws rest on the treadmill 





Figure 26. Synchronous and asynchronous behaviors correlate with different types of 
peaks. The blue recording represents the right striatum and the green recording represents 
the left striatum. We observed 13 different behaviors listed on the left side of the figure and 5 
different types of neuronal synchrony shown on the top. We then calculated a heatmap based 




Figure 27. Treadmill motor skill learning in the direct and indirect 
paths. Top calcium peaks in the indirect path during forward walking show 
a decrease between day 6 and day 7 and this reduction is maintained 
throughout day 14 (two-way ANOVA P<.05). Calcium peaks during reverse 
walking (dark red) show a decrease from day 1 through day 7. Bottom: 
Calcium peaks in the indirect path during forward walking show a decrease 
between day 6 and day 7 and this reduction is maintained throughout day 
14. Calcium peaks during reverse walking (dark red) show a decrease from 










Figure 28. Rotarod D1 (direct path) and A2A (indirect path) calcium peaks per minute. 
The number of peaks in the D1-Cre DMS mice showed a significant increase in direct path firing 
between day 1 and day 2, indicating increased recruitment of the associative path (Two tailed T 
test). The A2-Cre mice (DLS) showed a non-significant trend toward high activation of the 
indirect path on day 1 and reduced activation of the indirect path on day 2 indicating reduced 






Figure 29. Parallel bars calcium peaks per minute A2A mice. The A2-Cre 
mice showed non-significant trend toward high activation on day 1 and 
reduced activation on day 2 indicating reduced activity in the sensorimotor 
path. Recorded from fibers implanted in the DLS. (Two tailed T test) 
 
Figure 30. Highbar peaks per minute in A2A mice. The A2-Cre mice 
showed non-significant trend toward high activation on day 1 and reduced 
activation on day 2 indicating reduced activity in the sensorimotor path. 




This is to our knowledge the first evidence of synchronous and asynchronous activity between the right 
and left dorsal striatum, as determined by both amplitude and frequency of firing during goal oriented 
behaviors in mice (Figure 26). During the execution of motor patterns, unilateral peaks and bilateral 
asynchronous peaks were much more common than synchronous peaks.  Unique behaviors were also 
correlated to unique co-ordination of firing between right and left hemispheres. Different behavioral 
patterns showed unique firing patterns suggesting recruitment of diverse neuronal populations. These 
findings would be consistent with recordings showing specific neurons are tuned to fire during specific 
parts of an action sequence and that neuronal activity is concatenated during motor learning (Jin et al. 
2014).  
This is also the first evidence that the firing rate of the dSPNs of the direct path significantly decreases 
during motor learning in the DLS on the treadmill (Figure 27). We also found a trend toward decreasing 
firing rate of the indirect path neurons in the DLS on the rotarod, parallel bars, and highbar (Figures 28-
30). Similar to Kupferschmidt et al.  (2017), we found that the DLS showed the highest activity at the start 
of motor learning and that this level of activity rapidly reduced over subsequent days of training. We also 
found that iSPNs in the DMS showed low activity on the first day of training that rapidly increased by the 
second day of training. However, the recordings in the DMS showed a trend towards increasing on the 
second day of learning on the rotarod that did not reach significance (Figure 28). This would be relatively 
consistent with the findings from the sensorimotor terminals from Kupferschmidt et al. (2017):  however, 
while Kupferschmidt measured changes in the presynaptic corticostriatal neurons of the associative path 
projecting to SPNs in the DMS, and the corticostriatal neurons of the sensorimotor path projecting to 
neurons in the DLS, we were able to record from the next step in the circuit, the post synaptic SPNs of 
direct and indirect paths that comprise the associative and sensorimotor paths. We believe that this 
reduction in firing could be due to refinement of the populations of neurons that are involved during motor 
learning. This potential refinement could be explained by the neuronal ensemble hypothesis, that 
neuronal circuits undergo refinement during learning (Fingelkurts et al. 2004). This is supported by 
evidence showing specific neurons are active during different action sequences during motor pattern 
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learning (Jin et al. 2014). This is also supported by optical recordings showing that action sequences are 
encoded by specific neuronal ensembles (Klaus et al. 2017). 
Our findings suggest that the presynaptic changes that have been shown to underlie the changes in the 
firing rate of the sensorimotor and associative path corticostriatal neurons likely control the firing rate of 
the postsynaptic SPNs in both the direct and indirect paths. There may be a potential common 
mechanism underlying these changes, but while we were able to record these changes in firing in vivo, 
we were not able to determine if these changes were due to pre- or postsynaptic alterations or a 
combination of both.  
It is possible that DA and cannabinoid modulation plays an important role the changes in dSPN and iSPN 
firing that we observed. Previous studies have shown that DA changes in synaptic plasticity in 
corticostriatal and thalamostriatal synapses play a role in motor learning (Budzillo et al. 2017). DA and 
endocannabinoids control filtering in corticostriatal synapses and play a role in refining the information 
transmitted from the motor cortex to the striatal synapses. By mediating up and down state changes, DA 
also plays a direct role in the balance of direct and indirect path firing (Kreitzer 2009) 
Future directions 
We used a small number of experimental subjects as related in the Methods, and in future experiments, 
we plan to increase the number of mice sampled, which we likely allow these changes to reach 
significance. Now that the problems with the reverse light cycle room have been fixed (the light switches 
were deactivated), we plan to repeat the parallel bars, high bar, and rotarod for the full 7 days of motor 
training. Coordinated signaling by DA, glutamate, and endocannabinoids have been shown to play an 
important role in striatal plasticity (Wong et al. 2015). Long term depression of corticostriatal and 
thalamostriatal synapses was shown to be driven by retrograde transmission of endocannabinoids acting 
at CB1 receptors (Wong et al. 2015), and has been implicated in motor learning and action initiation (Jin 
and Costa 2015, Hilario and Costa 2008). We plan on using DA and cannabinoid antagonists during 
these tasks to investigate if they disrupt the firing rate of the dSPNs and iSPNs and to determine if they 
will impair motor skill learning.  
